Introduction {#s1}
============

Neurotransmitter release from presynaptic terminals is the primary mechanism of synaptic communication and is mediated by fusion of synaptic vesicles (SVs) with the plasma membrane at specific sites known as active zones (AZs) ([@bib65]; [@bib125]; [@bib153]). A highly conserved protein machinery composed of the SNARE complex drives fusion between the SV and AZ lipid bilayers ([@bib79]; [@bib122]; [@bib128]; [@bib130]). Ca^2+^ influx through voltage-gated Ca^2+^ channels functions as the trigger to activate the fusion process ([@bib16]; [@bib67]; [@bib66]; [@bib118]; [@bib124]). The majority of SVs fuse during a synchronous phase that occurs within a few milliseconds of Ca^2+^ entry ([@bib16]; [@bib47]; [@bib81]; [@bib114]; [@bib151]). Many synapses also have an asynchronous component that results in SV release over hundreds of milliseconds ([@bib47]; [@bib54]; [@bib64]; [@bib151]). Asynchronous release normally accounts for less than 5% of SV fusion following single action potentials at *Drosophila *neuromuscular junctions (NMJs) ([@bib62]). This slower phase of release becomes more prominent during high rates of stimulation ([@bib6]; [@bib83]; [@bib113]; [@bib157]) and mediates all SV fusion at some neuronal connections ([@bib13]; [@bib106]). Changes in the kinetics and amount of SV fusion also occur during high frequency stimulation, resulting in facilitation or depression depending on the synapse ([@bib157]). Defining the molecular machinery and Ca^2+^ sensors that regulate the distinct modes and kinetics of SV release is essential for understanding synaptic transmission.

The Synaptotagmin (SYT) family of Ca^2+^ binding proteins contain key regulators that control the timing of SV release. SYT proteins have a transmembrane domain and two Ca^2+^ binding C2 domains termed C2A and C2B ([@bib1]; [@bib2]; [@bib105]; [@bib127]; [@bib133]). Mammals have three SYT family members that localize to SVs (SYT1, SYT2 and SYT9), while *Drosophila* contains a single member of the SV subfamily (SYT1) ([@bib76]; [@bib101]; [@bib146]). These SYT isoforms bind Ca^2+^ and activate synchronous fusion of SVs via interactions with membranes and the SNARE complex ([@bib23]; [@bib24]; [@bib40]; [@bib45]; [@bib50]; [@bib71]; [@bib72]; [@bib78]; [@bib77]; [@bib86]; [@bib99]; [@bib130]; [@bib146]; [@bib151]; [@bib152]). Beyond SV localized SYTs, SYT7 is the only other family member implicated in Ca^2+^-dependent SV trafficking, although additional SYT isoforms participate in Ca^2+^-dependent fusion of other secretory organelles and dense core vesicles (DCVs) ([@bib1]; [@bib20]; [@bib32]; [@bib73]; [@bib95]; [@bib103]; [@bib120]; [@bib149]).

Multiple mechanisms have been proposed to mediate the asynchronous component of neurotransmitter release, including distinct Ca^2+^ sensors, heterogeneity in SV protein content, SV distance from Ca^2+^ channels, distinct Ca^2+^ entry pathways, or regulation of Ca^2+^ extrusion and buffering ([@bib22]; [@bib41]; [@bib64]; [@bib102]; [@bib113]; [@bib157]). Although several mechanisms may contribute, the observation that *Syt1* mutants have enhanced asynchronous release indicates another Ca^2+^ sensor(s) activates the remaining slower Ca^2+^-dependent component of exocytosis ([@bib58]; [@bib68]; [@bib99]; [@bib132]; [@bib148]; [@bib150]; [@bib151]). SYT7 has emerged as a popular candidate for the asynchronous Ca^2+^ sensor ([@bib7]; [@bib26]; [@bib89]; [@bib132]; [@bib131]; [@bib142]; [@bib143]). SYT7 has also been postulated to function as the Ca^2+^ sensor for short-term synaptic facilitation ([@bib26]; [@bib59]; [@bib131]). SYT7 has higher Ca^2+^ sensitivity, tighter membrane-binding affinity and longer Ca^2+^-lipid disassembly kinetics than SYT1 ([@bib56]; [@bib127]; [@bib126]; [@bib136]). These properties suggest SYT7 may regulate SV dynamics farther away from the AZ Ca^2+^ nanodomains that are required for SYT1 activation, or during temporal windows following the decay of the initial peak of Ca^2+^ influx. Together, these data have led to a two Ca^2+^ sensor model for evoked SV exocytosis, with SYT1 triggering the rapid synchronous phase of neurotransmitter release and SYT7 mediating asynchronous fusion and facilitation.

Although SYT7 manipulations can alter asynchronous release and facilitation at some synapses, several studies have suggested alternative explanations or identified unrelated defects in SV trafficking ([Figure 1A](#fig1){ref-type="fig"}). The recent observation that asynchronous release at mammalian synapses is anti-correlated with the levels of the synchronous Ca^2+^ sensors SYT1 and SYT2, but does not correlate with SYT7, prompted re-interpretation of earlier data on the protein's function ([@bib132]). Besides asynchronous release and facilitation, mammalian SYT7 has been implicated in SV endocytosis, SV replenishment, SV pool mobility, and DCV fusion and replenishment ([@bib8]; [@bib37]; [@bib38]; [@bib44]; [@bib51]; [@bib74]; [@bib80]; [@bib119]; [@bib129]; [@bib135]; [@bib145]). SYT7 has also been shown to regulate cell migration, lysosomal fusion and membrane repair in non-neuronal cells ([@bib11]; [@bib21]; [@bib27]; [@bib30]; [@bib42]; [@bib60]; [@bib88]; [@bib109]; [@bib155]).

![SYT1 and SYT7 comparison and generation of *Syt7* mutants.\
(**A**) Proposed roles for SYT7 in Ca^2+^-regulated membrane trafficking. (**B**) Phylogenetic tree of SYT1, SYT7 and E-SYT2 from the indicated species generated using the BLOSUM62 matrix with neighbor joining clustering. (**C**) Comparison of the structure of the C2A and C2B domains of *R. norvegicus* SYT1 (magenta) with a homology model of *D. melanogaster* SYT7 (blue). The C2B residues that form the SYT1-SNARE complex primary binding site are highlighted in yellow, with the counterpart changes noted in SYT7. The C2B HB helix in SYT1 is highlighted in green and missing from SYT7. (**D**) Diagram of the *Syt7* genomic locus on chromosome four with coding exons indicated with boxes. Exon 1 (teal) encodes the intravesicular and transmembrane (TM) domains; exons 2 and 3 (white) encode the linker region; exons 4 and 5 encode the C2A domain (dark blue); and exons 6 and 7 encode the C2B domain (light blue). The location of the *Syt7^M2^* Minos transposon insertion in exon two is indicated in red. Sequence of the *Syt7^M1^* CRISPR mutant versus control is shown below with the start codon in green. The guide RNA sequence used to target *Syt7* is bolded, with the cleavage site noted by the red arrowhead and the deleted cytosine with a red dash. (**E**) Western blot of SYT7 protein levels in head extracts of *white*, CRISPR control, *Syt7^M1^*, *Syt7^M2^* and *elav^C155^*-GAL4; UAS-*Syt7* (OE SYT7) with anti-SYT7 antisera (top panel). Syntaxin 1 (SYX1) antisera was used as a loading control (bottom panel). SYT7 is overexpressed 2.48 ± 0.4 fold compared to controls (p\<0.05, Mann-Whitney unpaired t-test, n = 4).](elife-55443-fig1){#fig1}

Similar to the uncertainty surrounding SYT7 function, its subcellular localization is also unclear, with different studies localizing the protein to the plasma membrane, DCVs, lysosomes, endosomes or other internal compartments ([@bib1]; [@bib30]; [@bib42]; [@bib88]; [@bib92]; [@bib96]; [@bib119]; [@bib120]; [@bib126]; [@bib155]). A key supporting argument for SYT7 as the asynchronous Ca^2+^ sensor is its reported localization to the AZ plasma membrane, positioning it at sites of SV fusion ([@bib126]). If SYT7 were present on endosomes or other internal membrane compartments, it would be more compatible with a role in SV trafficking rather than the fusion process itself. In summary, conflicting studies have generated confusion over how SYT7 contributes to neurotransmission and if the protein plays distinct roles across different neuronal subpopulations or species.

To examine the function of SYT7 in *Drosophila,* we generated and characterized *Syt7* null mutants. The *Drosophila *NMJ exhibits similar asynchronous release and facilitation properties to those of mammals ([@bib61]; [@bib62]; [@bib151]), making it a useful system to examine evolutionary conserved functions of SYT7 in neurotransmitter release. We found *Syt7* mutants and *Syt1; Syt7* double mutants display increased evoked neurotransmitter release, indicating SYT7 negatively regulates SV fusion independent of SYT1. In addition, CRISPR-mediated tagging of the endogenous *Syt7* locus indicates SYT7 localizes to a tubular network inside the presynaptic terminal that resides within the peri-active zone (peri-AZ) region, but is not enriched at sites of SV fusion. These data define a role for SYT7 in restricting SV availability and release, and indicate SYT7 is not a major Ca^2+^ sensor for asynchronous fusion and facilitation in *Drosophila.*

Results {#s2}
=======

Evolutionary conservation and structural comparison of SYT1 and SYT7 {#s2-1}
--------------------------------------------------------------------

Synaptotagmins form one of the largest protein families involved in membrane tracking, with 17 *Syt* genes encoded in mammals and 7 *Syt* genes found in *Drosophila *([@bib2]; [@bib29]; [@bib127]). Unlike the SV subfamily of SYTs, only a single *Syt7* gene is present in vertebrate and invertebrate genomes, making phenotypic comparisons easier. To examine the evolutionary relationship between SYT1, SYT7 and the more distantly related extended-Synaptotagmin (E-SYT) proteins, a phylogenetic tree was generated using the BLOSUM62 matrix and neighbor joining clustering analysis with protein sequences from placozoa (*Trichoplax adhaerens*), invertebrates (*Caenorhabditis elegans*, *Drosophila melanogaster, Ciona intestinalis*) and vertebrates (*Danio rerio*, *Rattus norvegicus*, *Homo sapiens*, [Figure 1B](#fig1){ref-type="fig"}). Although Trichoplax lacks neurons, it is the earliest metazoan that encodes *Syt* genes and contains both a SYT1 and SYT7 homolog ([@bib9]). The phylogenetic tree contains independent clusters that correspond to the SYT1, SYT7 and E-SYT2 protein families. The clustering of SYT1 homologs across evolution correlates with nervous system complexity, with the Trichoplax homolog forming the outlier member of the cluster. Within the SYT7 cluster, *C. elegans* SYT7 is the most distantly related member, with the Trichoplax homolog residing closer within the cluster. *Drosophila *SYT7 is more distant from the vertebrate subfamily clade than is *Drosophila *SYT1 within its subfamily, suggesting SYT7 sequence conservation is not as closely related to nervous system complexity as SYT1. These observations are consistent with SYT7's broader expression pattern and function within neuronal and non-neuronal cells ([@bib85]).

To compare SYT1 and SYT7 proteins, we performed homology modeling between *Drosophila *SYT7 and the published structure of mammalian SYT7 (*R. norvegicus* SYT7; PBD: 6ANK) ([@bib136]). Key structural features are highly conserved in the homology model, including the eight-stranded β-barrel and the Ca^2+^ binding loops that form the core of C2 domains ([Figure 1C](#fig1){ref-type="fig"}). In contrast to SYT1, both *Drosophila *and mammalian SYT7 lack the C2B HB helix previously found to have an inhibitory role in SV fusion ([@bib147]). We next performed sequence alignment of SYT proteins from *H. sapiens*, *R. norvegicus* and *D. melanogaster* ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). *Drosophila* SYT7 is 59% identical to human SYT7. Comparing the SYT1 and SYT7 subfamilies, the N-terminus encoding the transmembrane domain and linker region has the greatest variability and shares only 21% identity. Within the C2 domains, there is 100% conservation of the negatively charged Ca^2+^ binding residues in the C2 loops. A polybasic stretch in the C2B domain that mediates Ca^2+^-independent PI(4,5)P2-lipid interactions is also conserved. These sequence conservations indicate Ca^2+^-dependent and Ca^2+^-independent membrane binding are key properties of both SYT proteins.

Beyond lipid binding, SYT1's interaction with the SNARE complex is essential for its ability to activate SV fusion. Five key C2B residues (S332, R334, E348, Y391, A455) form the primary interaction site that docks SYT1 onto the SNARE complex ([@bib50]; [@bib156]). Four of the five primary SNARE binding residues are not conserved in *Drosophila *SYT7 ([Figure 1C](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). In addition, *Drosophila *and mammalian SYT7 contain specific amino acids substitutions at two of these residues that block SNARE binding and abolish SYT1 function in SV fusion ([@bib50]), including C285 (corresponding to *Syt1* mutant R334C) and K299 (corresponding to *Syt1* mutant E348K). A secondary SNARE complex-binding interface on SYT1 is mediated by conserved basic residues at the bottom on the C2B β-barrel (R451/R452 in *Drosophila* R388/R389 in rodents) and is also not conserved in the SYT7 subfamily ([@bib140]; [@bib147]; [@bib156]). As such, SYT7 is unlikely to engage the SNARE complex via the primary or secondary C2B interface, highlighting a key difference in how the proteins regulate membrane trafficking. Beyond SNARE-binding, 20 nonsynonymous amino acid substitutions are conserved only in the SYT1 or SYT7 subfamilies, suggesting additional interactions have likely diverged during evolution from the common ancestral SYT protein. In summary, SYT1 and SYT7 likely regulate membrane trafficking through distinct mechanisms, consistent with chimeric SYT1/SYT7 rescue experiments in mammals ([@bib147]).

Generation of *Drosophila Syt7* mutations {#s2-2}
-----------------------------------------

To assay SYT7 function in *Drosophila* the CRISPR-Cas9 system was used to generate null mutations in the *Syt7* locus. Using a guide RNA targeted near the *Syt7* start codon, several missense mutations were obtained. To disrupt the coding frame of *Syt7*, a single base pair cytosine deletion mutant (*Syt7^M1^*) located seven amino acids downstream of the start codon was used for most of the analysis, with an unaffected Cas9 injection line as control ([Figure 1D](#fig1){ref-type="fig"}). A Minos transposon insertion in the second coding exon of *Syt7* was also identified from the BDGP gene disruption project ([@bib12]) that generates a premature stop codon before the C2A domain, providing a second independent allele (*Syt7^M2^*) in a distinct genetic background ([Figure 1D](#fig1){ref-type="fig"}). To characterize the effects of SYT7 overexpression, a UAS-*Syt7* transgene was crossed with the neuronal *elav^C155^*-GAL4 driver. Western blot analysis of adult brain extracts with anti-SYT7 antisera confirmed the absence of SYT7 protein in *Syt7^M1^* and *Syt7^M2^* mutants and a 2.5-fold increase in SYT7 protein levels in *elav^C155^*-GAL4; UAS-*Syt7* ([Figure 1E](#fig1){ref-type="fig"}). Similar to the loss of SYT7 in mice ([@bib89]), *Drosophila Syt7* null mutants are viable and fertile with no obvious behavioral defects.

Dose-dependent regulation of neurotransmitter release by SYT7 {#s2-3}
-------------------------------------------------------------

To assay SYT7's role in synaptic transmission, two-electrode voltage clamp (TEVC) recordings were performed at glutamatergic NMJs from 3^rd^ instar larval motor neurons at segment A3 muscle 6 in 2 mM extracellular Ca^2+^. No significant changes in spontaneous release parameters were identified, as miniature excitatory junctional current (mEJC) amplitude, kinetics and frequency were similar between *Syt7^M1^* mutants, *Syt7^M1^* heterozygotes (*Syt7^M1^*/+) and controls ([Figure 2A--D](#fig2){ref-type="fig"}). In contrast to spontaneous release, evoked SV fusion (excitatory evoked junctional current (eEJC)) was dramatically enhanced in *Syt7^M1^* single mutants and elevated to an intermediate level in *Syt7^M1^* heterozygotes ([Figure 2E,F](#fig2){ref-type="fig"}; control: 158.33 ± 19.13 nA, n = 9; *Syt7^M1^*/+: p\<0.05, 233.08 ± 19.16 nA, n = 14; *Syt7^M1^*: p\<0.005, 262.96 ± 13.01 nA, n = 10). Although evoked release was increased \~2 fold, there was no change in eEJC kinetics in *Syt7^M1^* or *Syt7^M1^*/+ ([Figure 2G,H](#fig2){ref-type="fig"}). In addition, eEJC half-width was unaffected ([Figure 2I](#fig2){ref-type="fig"}). Loss of SYT7 increased evoked release regardless of whether quantal content was estimated using eEJC amplitude (which primarily measures synchronous release, 98% increase, [Figure 2J](#fig2){ref-type="fig"}) or eEJC charge (which measures both synchronous and asynchronous release, 128% increase, [Figure 2K](#fig2){ref-type="fig"}). The enhanced evoked release in *Syt7^M1^* was observed over a large range of extracellular \[Ca^2+^\] spanning from 0.175 to 2 mM ([Figure 2L](#fig2){ref-type="fig"}). Although the Ca^2+^ response curve shifted leftward over the entire range in *Syt7^M1^*, regression analysis revealed no significant difference in the Ca^2+^ cooperativity of release (control: 2.98 ± 0.17 (n = 7 larvae); *Syt7^M1^*: 2.69 ± 0.50 (n = 7 larvae), p=0.53). We conclude that loss of SYT7 enhances evoked SV release with no major effect on release kinetics or Ca^2+^ cooperativity at *Drosophila *NMJs.

![*Syt7* mutants and *Syt7*/+ heterozygotes display enhanced neurotransmitter release.\
(**A**) Average mEJC traces in control (black), *Syt7^M1^*/+ (green) and *Syt7^M1^* mutants (blue). (**B**) Quantification of mean mEJC amplitude for the indicated genotypes (control: 0.62 ± 0.020 nA, n = 17; *Syt7^M1^*/+: 0.61 ± 0.021 nA, n = 21; *Syt7^M1^*: 0.57 ± 0.013 nA, n = 20). (**C**) Normalized cumulative mEJC charge for each genotype. (**D**) Quantification of mean mEJC frequency for the indicated genotypes (control: 1.30 ± 0.10 Hz, n = 17; *Syt7^M1^*/+: 1.66 ± 0.13 Hz, n = 19; *Syt7^M1^*: 1.36 ± 0.12 Hz, n = 19). (**E**) Average eEJC traces in control (black), *Syt7^M1^*/+ (green) and *Syt7^M1^* (blue). (**F**) Quantification of mean eEJC amplitude for the indicated genotypes. (**G**) Average normalized responses for each genotype plotted on a semi-logarithmic graph to display release components. (**H**) Cumulative release normalized to the maximum response in 2 mM Ca^2+^ for each genotype. (**I**) Quantification of mean eEJC half-width in the indicated genotypes (control: 7.81 ± 0.47 ms, n = 9; *Syt7^M1^*/+: 7.77 ± 0.26 ms, n = 14; *Syt7^M1^*: 7.15 ± 0.34 ms, n = 10). (**J**) Quantification of evoked quantal content with mEJC amplitude for the indicated genotypes (control: 250.1 ± 30.58 SVs, n = 9; *Syt7^M1^*/+: 377.9 ± 31.13, n = 14; *Syt7^M1^*: 495.3 ± 36.75, n = 10). (**K**) Quantification of evoked quantal content with mEJC charge for the indicated genotypes (control: 221.3 ± 20.54 SVs, n = 9; *Syt7^M1^*/+: 371.6 ± 43.56, n = 14; *Syt7^M1^*: 503.6 ± 31.99, n = 10). (**L**) Log-log plot for eEJC amplitudes recorded in 0.175, 0.2, 0.3, 0.4, 0.6, 0.8, 1, and 2 mM extracellular \[Ca^2+^\] from control (black) and *Syt7^M1^* mutants (blue), with a Hill fit for each genotype noted. Recordings were performed from 3^rd^ instar segment A3 muscle 6. Extracellular \[Ca^2+^\] in **E--K** was 2 mM. Statistical significance was determined using one-way ANOVA (nonparametric) with post hoc Tukey's multiple comparisons test. N.S. = no significant change. Error bars represent SEM.](elife-55443-fig2){#fig2}

The synaptic levels of SYT7 are likely to be rate-limiting for its ability to regulate synaptic transmission since *Syt7^M1^*/+ heterozygotes displayed an intermediate increase in evoked release compared to *Syt7^M1^* null mutants. To determine if the effects of SYT7 are dosage-sensitive, SYT7 was overexpressed 2.5-fold by driving a UAS-*Syt7* transgene with neuronal *elav^C155^*-GAL4 ([Figure 1E](#fig1){ref-type="fig"}). Overexpression of SYT7 had no significant effect on spontaneous mEJC kinetics or amplitude ([Figure 3A,B](#fig3){ref-type="fig"}), similar to the lack of effect in *Syt7* null mutants. However, SYT7 overexpression resulted in a \~ 2 fold decrease in mEJC frequency ([Figure 2C](#fig2){ref-type="fig"}, p\<0.05), suggesting elevated levels of SYT7 can reduce spontaneous fusion. Unlike the increased evoked release in *Syt7^M1^* and *Syt7^M1^*/+ mutants, SYT7 overexpression caused a striking reduction in eEJC amplitude ([Figure 3D,E](#fig3){ref-type="fig"}) and eEJC charge ([Figure 3F](#fig3){ref-type="fig"}), with only mild effects on SV release kinetics ([Figure 3G](#fig3){ref-type="fig"}). To determine if the inhibitory action of SYT7 on SV release is secondary to a presynaptic role, SYT7 was overexpressed postsynaptically using the muscle specific *Mhc*-GAL4 driver. Overexpression of SYT7 in muscles had no effect on eEJC amplitude or kinetics ([Figure 3---figure supplement 1A, B](#fig3s1){ref-type="fig"}). We conclude that increased presynaptic SYT7 levels reduce both spontaneous and evoked SV release, indicating SYT7 functions as a negative regulator of neurotransmission.

![Neuronal overexpression of SYT7 reduces spontaneous and evoked SV release.\
(**A**) Average mEJC traces in control (black) and *elav^C155^*-GAL4; UAS-*Syt7* (OE SYT7, magenta). (**B**) Quantification of mean mEJC amplitudes in the indicated genotypes (control: 0.66 ± 0.03 nA, n = 9; OE SYT7: 0.73 ± 0.03 nA, n = 8). (**C**) Quantification of mean mEJC frequency in the indicated genotypes (control: 2.81 ± 0.42 Hz, n = 9; OE SYT7: 1.45 ± 0.18 Hz, n = 8). (**D**) Average eEJC traces in control (black) and *elav^C155^*-GAL4; UAS-*Syt7* (OE SYT7, magenta). (**E**) Quantification of mean eEJC amplitudes in the indicated genotypes (control: 256.24 ± 22.38 nA, n = 10; OE SYT7: 166.66 ± 10.74 nA, n = 7). (**F**) Quantification of mean eEJC charge in the indicated genotypes (control: 2.5 × 10^3^ ± 0.25 × 10^3^ nA\*ms, n = 10; OE SYT7: 1.4 × 10^3^ ± 0.12 × 10^3^ nA\*ms, n = 7). (**G**) Average normalized responses for each genotype plotted on a semi-logarithmic graph to display release components. Recordings were performed from 3^rd^ instar segment A3 muscle 6 in 2 mM Ca^2+^. Statistical significance was determined with a Mann-Whitney unpaired t-test.](elife-55443-fig3){#fig3}

Analysis of synaptic structure, AZ morphology and presynaptic Ca^2+^ influx in *Syt7* mutants {#s2-4}
---------------------------------------------------------------------------------------------

To determine if enhanced SV release in the absence of SYT7 results from an increase in AZ number or SV docking, synaptic morphology and ultrastructure at the NMJ was analyzed in *Syt7^M1^* mutants. Motor neurons form en passant synaptic boutons along the axon that contain hundreds of individual AZs marked by a central filamentous T-bar composed of the ELKS/CAST homolog Bruchpilot (BRP) ([@bib39]; [@bib138]). Immunostaining for BRP, the SV-associated protein Complexin (CPX) and a general marker for neuronal membranes (anti-HRP) was performed at muscle 6/7 and muscle 4, the two NMJs analyzed in this study ([Figure 4A--H](#fig4){ref-type="fig"}). There was no change in the total number of synaptic boutons ([Figure 4C,F](#fig4){ref-type="fig"}), AZ number defined by BRP puncta ([Figure 4D,G](#fig4){ref-type="fig"}), or AZ number per muscle surface area ([Figure 4E,H](#fig4){ref-type="fig"}). To examine the AZ T-bar where SVs cluster, high-resolution structured illumination microscopy (SIM) was performed on larval muscle 4 NMJs following anti-BRP immunostaining. *Syt7^M1^* mutants displayed the normal BRP ring architecture and showed no major difference in morphology compared to controls ([Figure 4I](#fig4){ref-type="fig"}). Individual T-bar size and intra-terminal T-bar spacing was quantified in controls and *Syt7^M1^* mutants on a Zeiss Airyscan confocal. Although BRP ring structure was intact, *Syt7^M1^* mutants displayed a 25% decrease in the average volume of individual BRP-labeled T-bars ([Figure 4J](#fig4){ref-type="fig"}), but no change in the spacing of T-bars relative to each other ([Figure 4K](#fig4){ref-type="fig"}). We conclude that loss of SYT7 does not disrupt overall AZ morphology or AZ number, though *Syt7^M1^* mutants display a mild decrease in T-bar volume.

![Analysis of synaptic morphology in *Syt7* mutants.\
(**A, B**) Immunocytochemistry of 3^rd^ instar muscle 6/7 NMJs with anti-HRP (blue), anti-CPX (magenta) and anti-BRP (green) in control and *Syt7^M1^*. The boxed region is magnified below with channels showing BRP, CPX and the merge. Scale bar = 20 µm for large panels and 2 µm for boxed regions. Synaptic morphology was quantified for 3^rd^ instar muscle 6/7 (**C--E**) and muscle 4 (**F--H**) in controls and *Syt7^M1^* mutants. No significant differences were detected in synaptic bouton number (**C, F**); muscle 6/7: p=0.78; control: 81.87 ± 5.301, n = 15; *Syt7^M1^*: 79.60 ± 5.824, n = 15; muscle 4: p=0.24; control: 55.86 ± 3.141, n = 14; *Syt7^M1^*: 62.50 ± 4.575, n = 14), BRP puncta (**D, G**), muscle 6/7: p=0.94; control: 621.1 ± 26.28, n = 15; *Syt7^M1^*: 618.1 ± 25.73, n = 15; muscle 4: p=0.83; control: 450.5 ± 23.25, n = 14; *Syt7^M1^*: 443.5 ± 21.47, n = 14) or BRP puncta per muscle surface area (**E, H**), muscle 6/7: p=0.13; control: 0.0088 ± 0.0004, n = 15; *Syt7^M1^*: 0.0098 ± 0.0005, n = 15; muscle 4: p=0.88; control: 0.0105 ± 0.0008, n = 14; *Syt7^M1^*: 0.0107 ± 0.0007, n = 14). (**I**) Anti-BRP staining at 3^rd^ instar muscle four in control and *Syt7^M1^* imaged with SIM microscopy. Scale bar = 1 µm. (**J**) Relative cumulative frequency of AZ T-bar volume defined with anti-BRP staining at 3^rd^ instar muscle 6/7 NMJs (p=0.026; control: 0.055 ± 0.004 µm^2^, n = 19 NMJs from five larvae; *Syt7^M1^*: 0.044 ± 0.003 µm^2^, n = 15 NMJs from four larvae). (**K**) Relative cumulative frequency of T-bar spacing defined by distance between nearest BRP puncta at 3^rd^ instar muscle 6/7 NMJs (p=0.48; control: 0.28 ± 0.016 µm, n = 20 NMJs from five larvae; *Syt7^M1^*: 0.27 ± 0.014 µm, n = 15 NMJs from four larvae). Statistical significance was determined with Student's t-test. (**L**) Mean fluorescence intensity of Fluo-4 AM in control (black) and *Syt7^M1^* mutants (blue) during the indicated stimulation protocol. (**M**) Representative images of synaptic boutons stained with anti-HRP (left), with Fluo-4 AM maximum fluorescence intensity during stimulation shown on the right for control (above) and *Syt7^M1^* (below). Scale bar = 1 µm.](elife-55443-fig4){#fig4}

To assay if increased release in *Syt7^M1^* mutants is secondary to elevated presynaptic Ca^2+^ influx, Ca^2+^ dynamics at NMJs were analyzed using Fluo-4 AM at 3^rd^ instar larval Ib motor terminals at segment A3 muscle 6/7 in control and *Syt7^M1^*. A stimulation paradigm consisting of three epochs of 10 Hz stimulation for 5 s separated by a 5 s rest period was performed ([Figure 4L](#fig4){ref-type="fig"}). Maximum presynaptic Flou-4 AM fluorescence during the stimulation paradigm was significantly greater in control than in *Syt7^M1^* (control: 10.7 × 10^6^ ± 1.25 × 10^6^, n = 11 NMJs from eight larvae; *Syt7^M1^*: 6.52 × 10^6^ ± 0.75 × 10^6^, n = 9 NMJs from eight larvae, p\<0.01, [Figure 4L,M](#fig4){ref-type="fig"}). These data indicate SYT7 does not suppress release by acting as a Ca^2+^ buffer or a negative regulator of Ca^2+^ channel function. Although the mechanism by which presynaptic Ca^2+^ influx is reduced in *Syt7* mutants is unknown, these data are consistent with the reduced AZ BRP volume ([Figure 4J](#fig4){ref-type="fig"}) and may represent a homeostatic response secondary to the enhanced release in *Syt7* mutants.

To determine if enhanced SV docking could increase the number of SVs available for release in *Syt7* mutants, SV distribution was quantified at larval muscle 6/7 NMJs in control and *Syt7^M1^* using transmission electron microscopy (TEM, [Figure 5A](#fig5){ref-type="fig"}). No change in overall SV density was observed within *Syt7^M1^* boutons, indicating SV recycling is largely unperturbed ([Figure 5B](#fig5){ref-type="fig"}). In contrast to the mild decrease in T-bar area ([Figure 4J](#fig4){ref-type="fig"}), there was no change in the length of individual AZs defined by the electron dense synaptic cleft ([Figure 5C](#fig5){ref-type="fig"}, p=0.93; control: 404 ± 34.5 nm, n = 21 AZs from five larvae; *Syt7^M1^*: 409 ± 28.9 nm, n = 29 AZs from five larvae). To examine docking, SVs in contact with the plasma membrane under the T-bar (within 100 nm, [Figure 5D](#fig5){ref-type="fig"}) or just outside the T-bar (100 to 400 nm, [Figure 5E](#fig5){ref-type="fig"}) were quantified. No significant change in the number of SVs docked at the AZ plasma membrane was detected ([Figure 5D--F](#fig5){ref-type="fig"}), indicating morphological docking defined by EM is not altered in *Syt7^M1^* mutants. To quantify SV distribution in the cytoplasm around AZs, SV number was binned into four concentric hemi-circles from 100 to 400 nm radius centered on the T-bar. No significant difference in SV distribution was observed in any bin ([Figure 5G,H](#fig5){ref-type="fig"}), indicating the morphological distribution of SVs around T-bars is intact in the absence of SYT7. We conclude the enhanced release in *Syt7^M1^* mutants is not due to increased AZ number or docked SVs.

![Ultrastructural analysis of SV distribution in *Syt7* mutants.\
(**A**) Representative EM micrographs of muscle 6/7 synaptic boutons in control and *Syt7^M1^* 3^rd^ instar larvae. An AZ with its associated electron dense T-bar is denoted with an arrowhead in each micrograph. (**B**) Quantification of SV density (p=0.41; control = 0.34 ± 0.033 SVs/µm^2^, n = 20; *Syt7^M1^* = 0.30 ± 0.031 SVs/µm^2^, n = 20). (**C**) Quantification of AZ length defined by the electron dense synaptic cleft (p=0.93; control: 404 ± 34.5 nm, n = 21 AZs from five larvae; *Syt7^M1^*: 409 ± 28.9 nm, n = 29 AZs from five larvae). (**D**) Quantification of SVs docked within 100 nm of the T-bar (p=0.41; control = 1.69 ± 0.15 SVs n = 84; *Syt7^M1^* = 1.43 ± 0.15 SVs, n = 58). (**E**) Quantification of SVs docked within 100--400 nm of the T-bar (p=0.68; control = 2.46 ± 0.17 SVs n = 84; *Syt7^M1 ^*= 2.35 ± 0.25 SVs, n = 58). (**F**) Quantification of all docked SVs at 0--400 nm from the T-bar (p=0.31; control = 4.16 ± 0.23 SVs n = 84; *Syt7^M1^* = 3.78 ± 0.29 SVs, n = 58). (**G**) Quantification of all SVs within a 400 nm radius from the T-bar (p=0.38; control = 71.98 ± 4.05 SVs n = 84; *Syt7^M1^* = 78.12 ± 5.89 SVs, n = 58). (**H**) Quantification of SV distribution at AZs in control and *Syt7^M1^* mutants. Statistical significance was determined with Student's t-test.](elife-55443-fig5){#fig5}

Optical quantal mapping in *Syt7* mutants {#s2-5}
-----------------------------------------

Given quantal size ([Figure 2B](#fig2){ref-type="fig"}), AZ number ([Figure 4D,G](#fig4){ref-type="fig"}) and SV docking ([Figure 5H](#fig5){ref-type="fig"}) are unchanged in *Syt7* mutants, increased release probability (*P~r~*) at individual AZs is a candidate mechanism to mediate the elevated quantal content during single stimuli. We previously developed a quantal imaging approach to map AZ *P~r~* at *Drosophila *NMJs by expressing myristoylated GCaMP6s in muscles ([@bib3]; [@bib91]). Using this approach, *P~r~* maps for evoked release were generated for all AZs from Ib boutons at muscle 4 NMJs in control and *Syt7^M1^* mutants ([Figure 6A](#fig6){ref-type="fig"}). Similar to controls, AZs formed by single motor neurons in *Syt7^M1^* displayed heterogeneous *P~r~* ([Figure 6B](#fig6){ref-type="fig"}). However, *P~r~* distribution was strikingly different between the genotypes, with a greater number of high *P~r~* and fewer low *P~r~* AZs at *Syt7^M1^* NMJs ([Figure 6C](#fig6){ref-type="fig"}). *Syt7^M1^* NMJs also had fewer silent AZs that showed no release (control: 19.9%; *Syt7^M1^*: 4.6%). Overall, mean *P~r~* was increased 2-fold ([Figure 6D](#fig6){ref-type="fig"}, p\<0.01; control: 0.063 ± 0.002, n = 1158 AZs; *Syt7^M1^*: 0.12 ± 0.004, n = 768 AZs). In contrast, the maximum AZ *P~r~* in the two genotypes was unchanged ([Figure 6D](#fig6){ref-type="fig"}, control: 0.61; *Syt7^M1^*: 0.63), indicating an upper limit on release strength for single AZs that is similar between controls and *Syt7^M1^*. We conclude that the enhanced release in the absence of SYT7 results from an increase in average *P~r~* across the AZ population.

![Quantal imaging reveals elevated release probability across the AZ population in *Syt7* mutants.\
(**A**) Representative images of GluRIIA positive PSDs (red) and postsynaptic myr-GCaMP6 flashes (green) in response to evoked stimulation in control and *Syt7^M1^* mutants. (**B**) *P~r~* heatmaps for muscle 4 NMJs generated following 0.3 Hz stimulation for 5 min in control and *Syt7^M1^* mutants. The *P~r~* color map is displayed in the upper right. (**C**) Frequency distribution of AZ *P~r~* after a 0.3 Hz 5 min stimulation for control (black dashed line) and *Syt7^M1^* (blue line). (**D**) Quantification of mean AZ *P~r~* for the two genotypes (p≤0.01, Student's t-test; control: 0.063 ± 0.002, n = 1158; *Syt7^M2^*: 0.12 ± 0.004, n = 768).](elife-55443-fig6){#fig6}

Loss of SYT7 enhances SV release in *Syt1* null mutants {#s2-6}
-------------------------------------------------------

*Drosophila Syt1* null mutants have dramatically reduced synchronous SV fusion and enhanced asynchronous and spontaneous release ([@bib62]; [@bib71]; [@bib150]; [@bib151]). We generated *Syt1; Syt7* double mutants to determine if SYT7 mediates the residual asynchronous release present in *Syt1* nulls. A complete loss of asynchronous release in *Syt1; Syt7* double mutants should occur if SYT7 functions as the sole asynchronous Ca^2+^ sensor, while a reduction in release is expected if it is one of several sensors mediating the residual synaptic transmission in *Syt1*. Animals lacking SYT1 were obtained by crossing an intragenic *Syt1* deletion (*Syt1^N13^*) with a point mutant containing an early stop codon (*Syt1^AD4^*), an allelic combination referred to as *Syt1^Null^*. Loss of SYT1 results in lethality throughout development, although some *Syt1^Null^* mutants survive to adulthood when cultured under special conditions ([@bib82]). Surviving *Syt1^Null^* adults are severely uncoordinated and die within several days. Quantification of survival rates demonstrated 45.3% of *Syt1^Null^* mutants survived from the 1^st^ instar to the pupal stage, with 44.1% of mutant pupae surviving to adulthood (n = 5 groups with \>40 starting animals each). In contrast, 5.6% of *Syt1^Null^; Syt7^M2^* double mutants (referred to as *Double^Null^*) survived from the 1^st^ instar to the pupal stage, and 6.6% of mutant pupae survived to adulthood (n = 6 groups with \>80 animals each). Western blot analysis confirmed loss of both proteins in *Double^Null^* mutants and demonstrated no change in expression of SYT1 or SYT7 in the absence of the other family member in individual null mutant backgrounds ([Figure 7A](#fig7){ref-type="fig"}). Although loss of both SYTs caused synergistic defects in survival, residual synaptic transmission must exist given some *Double^Null^* mutants survive.

![Loss of SYT7 enhances the residual release observed in *Syt1* null mutants.\
(**A**) Western blot of head extracts from control, *Syt7^M2^*, *Syt1^Null^* and *Syt1^null^; Syt7^M2^* (*Double^Null^*) probed with anti-SYT7, anti-SYT1 and anti-SYX1 (loading control). SYT1 migrates as a doublet at 55 and 70 kD ([@bib76]). (**B**) Average mEJC traces in *Syt1^Null^* (black trace) and *Double^Null^* (red trace) mutants obtained by summing all mEPSC events under the first peak distribution. (**C**) Quantification of mean mEJC frequency for the indicated genotypes. (**D**) Average eEJC traces in *Syt1^Null^* (black trace) and *Double^Null^* (red trace). (**E**) Quantification of mean eEJC amplitude for the indicated genotypes. (**F**) Quantification of mean eEJC charge for the indicated genotypes obtained by measuring total release over time. (**G**) Average normalized responses for each genotype plotted on a semi-logarithmic graph to display release components. (**H**) Cumulative release normalized to the maximum response in 2 mM Ca^2+^ for each genotype. Each trace was adjusted to a double exponential fit. (**I**) Quantification of eEJC failure ratio (%) in the indicated genotypes. Recordings were performed from 3^rd^ instar segment A3 muscle 6 in 2 mM extracellular Ca^2+^. Statistical significance was determined with the Mann-Whitney unpaired t-test.](elife-55443-fig7){#fig7}

To assay synaptic transmission, recordings were performed from 3^rd^ instar larval muscle 6 in 2 mM extracellular Ca^2+^ in *Syt1^Null^* and *Double^Null^* mutants. No change in spontaneous mEJC amplitude or kinetics was found between the two genotypes ([Figure 7B](#fig7){ref-type="fig"}), indicating postsynaptic sensitivity, neurotransmitter loading, and fusion pore dynamics were not disrupted by loss of SYT7. However, a \~ 2 fold increase in mEJC frequency was observed in the *Double^Null^* compared to *Syt1^Null^* ([Figure 7C](#fig7){ref-type="fig"}, p\<0.001; *Syt1^null^*: 2.99 ± 0.23 Hz, n = 16; *Double^Null^*: 5.33 ± 0.42 Hz, n = 14), demonstrating loss of both SYTs enhances the already elevated spontaneous release rate found in *Syt1^Null^* mutants alone. Measurements of evoked release revealed both amplitude and charge transfer were increased \~2 fold in *Double^Null^* compared to *Syt1^Null^* mutants ([Figure 7D--F](#fig7){ref-type="fig"}; eEJC amplitude: p\<0.001; *Syt1^Null^*: 3.18 ± 0.4 nA, n = 15; *Double^Null^*: 6.12 ± 0.62 nA, n = 13; eEJC charge: p\<0.05; *Syt1^Null^*: 33.2 ± 4.4 nA\*ms, n = 15; *Double^Null^*: 52.6 ± 5.8 nA\*ms, n = 13). In addition, more SVs fused in the first 15 ms following stimulation ([Figure 7G,H](#fig7){ref-type="fig"}), with less SVs available for release later in the response. *Double^Null^* mutants also had a reduced rate of evoked failures following nerve stimulation compared to *Syt1^Null^*, consistent with an increased probability of SV release ([Figure 7I](#fig7){ref-type="fig"}, p\<0.01; *Syt1^Null^*: 21.1 ± 3.5% failure rate, n = 17; *Double^Null^*: 7.4 ± 3.4% failure rate, n = 14). These results indicate SYT7 does not mediate the residual release found in the absence of SYT1. We conclude SYT7 negatively regulates SV release with or without SYT1 present at the synapse.

Short-term facilitation does not require SYT7 {#s2-7}
---------------------------------------------

Although these results indicate SYT7 is a not a key asynchronous Ca^2+^ sensor in *Drosophila* the protein has also been implicated as the Ca^2+^ sensor for facilitation ([@bib26]; [@bib59]; [@bib131]), a short-term form of presynaptic plasticity that results in enhanced SV fusion during closely-spaced stimuli. To examine facilitation, \[Ca^2+^\] was lowered from 2 mM to 0.175 mM or 0.2 mM to identify conditions where the initial *P~r~* was matched between control and *Syt7* mutants. In 0.175 mM Ca^2+^, controls displayed an 11% failure ratio in response to single action potentials, while *Syt7^M1^* had no failures ([Figure 8A](#fig8){ref-type="fig"}). In 0.2 mM Ca^2+^, neither genotype had failures ([Figure 8A](#fig8){ref-type="fig"}), although evoked release was increased 3-fold in *Syt7^M1^* ([Figure 7B,C](#fig7){ref-type="fig"}, p\<0.01, control: 7.73 ± 1.5 nA, n = 9; *Syt7^M1^*: 23.72 ± 6.2 nA, n = 9). In contrast, EJC amplitude was not statistically different between control in 0.2 mM Ca^2+^ (7.73 ± 1.5 nA, n = 9) and *Syt7^M1^* in 0.175 mM Ca^2+^ (8.70 ± 1.6 nA, n = 9). Facilitation was assayed in these conditions where initial *P~r~* was comparable. Control and *Syt7^M1^* mutants displayed robust facilitation to paired pulses separated by 10 or 50 ms at both Ca^2+^ concentrations ([Figure 8D](#fig8){ref-type="fig"}). A modest reduction in paired-pulse ratio was observed in *Syt7^M1^* at 0.175 Ca^2+^ compared to control at 0.2 mM Ca^2+^ ([Figure 8E,F](#fig8){ref-type="fig"}, p\<0.05; 10 ms interval: 31% decrease; 50 ms interval: 22% decrease). These data indicate SYT7 is not the sole effector of facilitation. The mild defect in *Syt7* mutants could be due to a partially redundant role for SYT7 in facilitation or secondary to differences in Ca^2+^ available to activate the true facilitation sensor. Given \[Ca^2+^\] was lowered in *Syt7^M1^* to match initial *P~r~* between the genotypes, the latter hypothesis is more likely.

![Short-term synaptic facilitation can occur without SYT7 or SYT1.\
(**A**) Quantification of eEJC failure ratio (%) in the indicated genotypes. (**B**) Average eEJC traces recorded in 0.175 mM Ca^2+^ (control, grey; *Syt7^M1^*, light blue) or 0.2 mM Ca^2+^ (control, black; *Syt7^M1^*, dark blue). (**C**) Quantification of mean eEJC amplitude for the indicated genotypes (0.175 mM Ca^2+^: control, 5.42 ± 2.0 nA, n = 7; *Syt7^M1^*, 8.70 ± 1.6 nA, n = 14; 0.2 mM Ca^2+^: control, 7.73 ± 1.5 nA, n = 9; *Syt7^M1^*, 23.72 ± 6.2 nA, n = 9). (**D**) Representative eEJC traces to 10 ms or 50 ms paired-pulse stimuli recorded in 0.2 mM Ca^2+^ (control, black; *Syt7^M1^*, dark blue) or 0.175 mM Ca^2+^ (*Syt7^M1^*, light blue). (**E**) Quantification of facilitation (P2/P1) at 10 ms interval for the indicated genotypes (0.2 mM Ca^2+^: control, 1.93 ± 0.095, n = 9; *Syt7^M1^*, 1.28 ± 0.12, n = 9; 0.175 mM Ca^2+^: *Syt7^M1^*, 1.47 ± 0.11, n = 12). (**F**) Quantification of facilitation (P2/P1) at 50 ms interval for the indicated genotypes (0.2 mM Ca^2+^: control, 1.64 ± 0.043, n = 9; *Syt7^M1^*, 1.23 ± 0.056, n = 9; 0.175 mM Ca^2+^: *Syt7^M1^*, 1.34 ± 0.054, n = 12). Statistical significance was determined using one-way ANOVA (nonparametric) with post hoc Tukey's multiple comparisons test for panels A-F. (**G**) Average eEJC quantal content determined from mEJC charge in 2 mM Ca^2+^ during a 10 Hz stimulation paradigm (30 stimuli at 0.5 Hz, 500 stimuli at 10 Hz, and return to 0.5 Hz) in *Syt1^Null^* (black) and *Double^Null^* (red). (**H**) Average quantal content for the last four responses of 0.5 Hz stimulation and the first 14 responses during 10 Hz stimulation in *Syt1^Null^* (black) and *Double^Null^* (red). P1 denotes the 1^st^ response and P2 the 2^nd^ response to 10 Hz stimulation. (**I**) Quantification of P2/P1 ratio in *Syt1^Null^* (black, 1.15 ± 0.089, n = 12) and *Double^Null^* (red, 1.55 ± 0.22, n = 13) at onset of 10 Hz stimulation. Statistical significance was determined with a Mann-Whitney unpaired t-test for panels H and I.](elife-55443-fig8){#fig8}

To determine if short-term facilitation could be elicited in the absence of both SYT1 and SYT7, a 10 Hz stimulation train in 2.0 mM Ca^2+^ was given to *Double^Null^* mutants and eEJC responses were compared to *Syt1^Null^* mutants alone. Similar to the increased quantal content to single action potentials, *Double^Null^* mutants displayed larger facilitating responses during the early phase of stimulation ([Figure 8G--I](#fig8){ref-type="fig"}; cumulative average release for 10 stimuli: *Syt1^Null^* (n = 12): 87 ± 7.0 quanta; *Double^Null^* (n = 13): 109 ± 9.9 quanta; 20 stimuli: *Syt1^Null^*: 209 ± 13.8 quanta; *Double^Null^*: 261 ± 22.6 quanta; 50 stimuli: *Syt1^Null^*: 594 ± 34.5 quanta; *Double^Null^*: 745 ± 56.2 quanta, p\<0.03). These results indicate short-term facilitation can occur in the absence of both SYT1 and SYT7, and is enhanced during the early phases of stimulation, consistent with SYT7 negatively regulating SV fusion with or without SYT1.

*Syt7* mutants have access to a larger pool of fusogenic SVs but maintain a normal rate of SV endocytosis at steady-state {#s2-8}
-------------------------------------------------------------------------------------------------------------------------

Enhanced SV release in *Syt7* mutants could reflect increased fusogenicity of the entire SV population or conversion of a non-fusogenic SV pool into one capable of release in the absence of SYT7. To test whether SYT7 normally renders a pool of SVs non-fusogenic, 1000 stimuli at 10 Hz were applied in 2 mM Ca^2+^ at 3^rd^ instar muscle 6 NMJs to deplete the readily releasable pool (RRP) and drive SV cycling to steady-state. The total number of released SVs and the SV recycling rate was then measured. Both control and *Syt7^M1^* eEJCs depressed during the stimulation train. However, SV release in *Syt7^M1^* mutants remained elevated over much of the initial stimulation ([Figure 9A](#fig9){ref-type="fig"}) and the integral of release during the train was greater than controls ([Figure 9B](#fig9){ref-type="fig"}), indicating *Syt7* nulls have access to more fusogenic SVs. SV release rate in *Syt7^M1^* eventually reached the same level as control following depletion of the RRP ([Figure 9C](#fig9){ref-type="fig"}, control quantal content: 131.5 ± 10.7, n = 7; *Syt7^M1^* quantal content: 123.1 ± 10.5, n = 8). We conclude that SV endocytosis and recycling rate is SYT7-independent at steady-state, although *Syt7^M1^* mutants contain a larger RRP available for fusion.

![*Syt7* mutants have a larger releasable pool of SVs and normal endocytosis.\
(**A**) Representative mean eEJC quantal content determined by mEJC charge during 1000 stimuli at 10 Hz in 2 mM Ca^2+^ in control (black) and *Syt7^M1^* (blue). The inset shows representative eEJC traces in control (black) and *Syt7^M1^* (blue). (**B**) Quantification of average cumulative quanta released during the 1000 stimuli at 10 Hz tetanic stimulation in control (black, 19.21K ± 2.88K, n = 7) and *Syt7^M1^* (blue, 36.18K ± 5.67K, n = 8). (**C**) Quantification of average quantal content at steady-state release at the end of the 10 Hz stimulation in control (black, 131.54 ± 10.71, n = 7) and *Syt7^M1^* (blue, 123.05 ± 10.47, n = 8). Statistical significance for B and C was determined with a Mann-Whitney unpaired t-test. (**D**) FM1-43 loading in control and *Syt7^M1^* larvae at muscle 6/7 NMJs in 2 mM Ca^2+^ following 150, 300 or 600 stimuli delivered at 0.5 Hz. (**E**) FM1-43 loading with 500 stimuli at 10 Hz in 2 mM Ca^2+^ and FM1-43 unloading with high K^+^ (90 mM) in control and *Syt7^M1^* larvae at muscle 6/7 NMJs. (**F**) Quantification of FM1-43 loading following 150, 300 or 600 stimuli delivered at 0.5 Hz. (**G**) Quantification of FM1-43 loading after 500 stimulati at 10 Hz. (**H**) Quantification of FM1-43 unloading with high K^+^ (90 mM). Statistical significance was determined with Student's t-test for F-H. Scale bar = 5 µm.](elife-55443-fig9){#fig9}

To further examine SV recycling, FM1-43 dye uptake and release assays were performed in control and *Syt7^M1^* mutants at 3^rd^ instar muscle 6/7 NMJs. At low stimulation rates (0.5 Hz), *Syt7^M1^* mutants took up significantly more FM1-43 dye than controls ([Figure 9D,F](#fig9){ref-type="fig"}), consistent with the increased SV release observed by physiology. In contrast, no significant difference in FM1-43 uptake was found following high frequency 10 Hz stimulation for 500 stimuli ([Figure 9E,G](#fig9){ref-type="fig"}). These data suggest previously exocytosed SVs re-enter the RRP more often in the absence of SYT7 given the normal recycling rate ([Figure 9C](#fig9){ref-type="fig"}). Consistent with this hypothesis, no change in FM1-43 release was detected with high \[K^+^\] stimulation following 10 Hz loading ([Figure 9H](#fig9){ref-type="fig"}). Together with the electrophysiology data, we conclude *Syt7* mutants have a larger RRP, but no changes in SV endocytosis.

*Syt7* mutants have enhanced refilling of the readily-releasable SV pool independent of endocytosis {#s2-9}
---------------------------------------------------------------------------------------------------

To probe how SYT7 regulates SV cycling and the transition between distinct SV pools, eEJC recovery kinetics following high frequency stimulation were characterized. A paradigm consisting of 30 stimuli at 0.5 Hz, 500 stimuli at 10 Hz and a final 50 stimuli at 0.5 Hz was given to *Syt7^M1^* mutants, *Syt7^M1^*/+ heterozygotes and controls in 2 mM Ca^2+^ ([Figure 10A](#fig10){ref-type="fig"}). During 0.5 Hz stimulation, *Syt7^M1^* and *Syt7^M1^*/+ displayed elevated levels of release. Following the onset of high frequency stimulation, *Syt7^M1^* and *Syt7^M1^*/+ synapses depressed while controls displayed a mild facilitation before quickly transitioning to depression ([Figure 10B](#fig10){ref-type="fig"}). Remarkably, *Syt7^M1^* and *Syt7^M1^*/+ displayed an extremely rapid recovery of eEJC amplitude and quantal content during the 2 s interval following termination of the 10 Hz train compared to controls ([Figure 10C](#fig10){ref-type="fig"}). A similar rapid recovery was observed in *Syt7^M1^* after 2000 stimuli were given at 10 Hz to fully deplete the RRP and normalize release rates to control levels ([Figure 10---figure supplement 1A--C](#fig10s1){ref-type="fig"}). These observations suggest SYT7 also functions to reduce SV entry into the RRP, while negatively regulating release of newly regenerated SVs. The enhanced refilling of the RRP did not require SYT1 function, as *Double^Null^* mutants also displayed larger eEJCs than *Syt1^Null^* alone during the recovery from a 10 Hz stimulation train ([Figure 8G](#fig8){ref-type="fig"}).

![*Syt7* mutants have enhanced refilling of the RRP that does not require endocytosis.\
(**A**) Average eEJC quantal content during the indicated stimulation protocol in 2 mM external Ca^2+^ for control (black), *Syt7^M1/+^* (green) and *Syt7^M1^* (blue). (**B**) Quantification of P2/P1 ratio (P1 = 1^st^ response to 10 Hz, P2 = 2^nd^ response to 10 Hz) in control (black, 1.13 ± 0.03, n = 8), *Syt7^M1/+^* (green, 0.95 ± 0.009, n = 14) and *Syt7^M1^* (blue, 0.82 ± 0.01, n = 8). Representative eEJC traces of P1 and P2 for control (black) and *Syt7^M1^* (blue) are shown on the right. (**C**) Quantification of P531/P530 ratio (P530 is the last response to 10 Hz and P531 is the 1^st^ response to 0.5 Hz stimulation delivered 2 s after P530) in control (black, 0.93 ± 0.06, n = 8), *Syt7^M1/+^* (green, 1.33 ± 0.04, n = 12) and *Syt7^M1^* (blue, 1.91 ± 0.09, n = 8). Representative eEJC traces of P530 and P531 for control (black) and *Syt7^M1^* (blue) are shown on the right. (**D**) Representative eEJC traces for control with DMSO (black) or 4 µM bafilomycin (gray) and *Syt7^M1^* with DMSO (dark blue) or 4 µM bafilomycin (light blue) in 2 mM external Ca^2+^ with the indicated stimulation protocol repeated three times. (**E**) Quantification of P531/P530 for the indicated genotypes (1^st^ stimulation protocol: Control + DMSO, 0.98 ± 0.056, n = 17; Control + bafilomycin, 1.53 ± 0.12, n = 17; *Syt7^M1^* + DMSO, 1.83 ± 0.058, n = 17; *Syt7^M1^* + bafilomycin, 2.10 ± 0.11, n = 17; 2^nd^ stimulation protocol: Control + DMSO, 0.97 ± 0.045, n = 17; Control + bafilomycin, 1.25 ± 0.064, n = 17; *Syt7^M1^* + DMSO, 1.95 ± 0.10, n = 17; *Syt7^M1^* + bafilomycin, 2.09 ± 0.19, n = 17). Statistical significance was determined with a one-way Anova with Sidak's multiple comparisons test. (**F**) Quantification of mean eEJC amplitudes for P530 and P531 for the indicated genotypes (1^st^ stimulation protocol: P530 in Control + DMSO, 87.39 ± 3.85, n = 17; P531 in Control + DMSO, 80.22 ± 5.25, n = 17; P530 in Control + bafilomycin, 44.68 ± 2.80, n = 17; P531 in Control + bafilomycin, 66.26 ± 5.03, n = 17; P530 in *Syt7^M1^* + DMSO, 97.62 ± 4.04, n = 17; P531 in *Syt7^M1^* + DMSO, 177.34 ± 7.80, n = 17; P530 in *Syt7^M1^* + bafilomycin, 52.44 ± 3.83, n = 17; P531 in *Syt7^M1^* + bafilomycin, 102.50 ± 8.07, n = 17; 2^nd^ stimulation protocol: P530 in Control + DMSO, 68.21 ± 3.97, n = 17; P531 in Control + DMSO, 70.05 ± 5.95, n = 17; P530 in Control + bafilomycin, 15.09 ± 1.26, n = 17; P531 in Control + bafilomycin, 18.15 ± 1.34, n = 17; P530 in *Syt7^M1^* + DMSO, 82.89 ± 4.64, n = 17; P531 in *Syt7^M1^* + DMSO, 163.52 ± 9.74, n = 17; P530 in *Syt7^M1^* + bafilomycin, 11.98 ± 1.26, n = 17; P531 in *Syt7^M1^* + bafilomycin, 24.71 ± 3.00, n = 17). Statistical significance was determined with a Student's paired t-test.](elife-55443-fig10){#fig10}

The partial elevation in RRP refilling rate at *Syt7^M1^*/+ synapses indicates the amount of SYT7 in the presynaptic terminal regulates SV entry into the releasable pool. To determine if RRP refilling is dosage-sensitive, the stimulation paradigm above (0.5 Hz/10 Hz/0.5 Hz) was applied to SYT7 overexpression larvae (*elav^C155^*-GAL4; UAS-*Syt7*) in 2 mM Ca^2+^. Presynaptic overexpression of SYT7 had the opposite effect of *Syt7* mutants and *Syt7*/+ heterozygotes, not only reducing eEJC amplitude at 0.5 Hz, but greatly limiting the ability of SVs to re-enter the RRP following termination of the 10 Hz stimulation train ([Figure 10---figure supplement 2A-C](#fig10s2){ref-type="fig"}). We conclude that SYT7 limits release in a dosage-sensitive manner by negatively regulating the number of SVs available for fusion and slowing recovery of the RRP following stimulation.

To determine if increased RRP refilling in *Syt7^M1^* requires an enhanced rate of SV endocytosis or is mediated through refilling from a pre-existing SV pool, recordings were repeated in the presence of the proton pump inhibitor bafilomycin. Bafilomycin blocks neurotransmitter reloading of newly endocytosed SVs and should eliminate the enhanced refilling of the RRP if recycling is essential. Alternatively, if SVs are recruited more rapidly from pre-existing pools, bafilomycin would not abolish the enhanced recovery. The same 0.5 Hz/10 Hz/0.5 Hz paradigm was applied in three successive epochs in the presence of 4 uM bafilomycin or DMSO (control) in the bath solution. As expected, bafilomycin progressively reduced eEJC amplitude throughout the experiment and eliminated most evoked responses during the 3^rd^ stimulation epoch ([Figure 10D](#fig10){ref-type="fig"}). *Syt7^M1^* mutants displayed a similar fold-enhancement in the recovery of the RRP in the presence of bafilomycin, though the absolute numbers of SVs re-entering the pool decreased following the 2^nd^ 10 Hz stimulation as the number of neurotransmitter-containing SVs declined ([Figure 10E,F](#fig10){ref-type="fig"}). We conclude that the rapid refilling of the RRP can occur from pre-existing SV pools. In addition to reducing fusogenicity of SVs already docked at the AZ, these data indicate SYT7 regulates transition kinetics between vesicle pools by reducing the number of SVs moving from the reserve pool to the RRP.

SYT7 localizes to an internal membrane network within the peri-AZ that resides in proximity to multiple presynaptic compartments {#s2-10}
--------------------------------------------------------------------------------------------------------------------------------

Defining the subcellular localization of SYT7 could help elucidate how it modulates SV dynamics. SYT7 could be a resident protein of the SV pool it regulates or reside on an alternative compartment that exerts control over a subset of SVs. To examine the subcellular localization of SYT7, an RFP tag was introduced at the 3'-end of the endogenous *Syt7* locus using CRISPR ([Figure 11A](#fig11){ref-type="fig"}). This approach generated a SYT7^RFP^ C-terminal fusion protein expressed under its endogenous enhancers to avoid any overexpression that might trigger changes in its normal localization. The RFP C-terminal fusion did not abolish SYT7 function, as eEJC amplitude in 2 mM Ca^2+^ was not significantly different between control and SYT7^RFP^ (control: 198.9 ± 8.8 nA, n = 14; SYT7^RFP^, 227 ± 11.3 nA, n = 14, p=0.1). A sfGFP version (SYT7^GFP^) was also generated with CRISPR that showed the same intra-terminal expression pattern as SYT7^RFP^ ([Figure 11---figure supplement 1A](#fig11s1){ref-type="fig"}). Western blot analysis with anti-RFP identified a single band at the predicted molecular weight (73kD) of the fusion protein in SYT7^RFP^ animals ([Figure 11B](#fig11){ref-type="fig"}), indicating a single SYT7 isoform is expressed in *Drosophila.* Immunostaining of 3^rd^ instar larvae with anti-RFP antisera revealed SYT7^RFP^ was enriched in presynaptic terminals and formed an expansive tubular network near the plasma membrane that extended into the center of the bouton ([Figure 11C,D](#fig11){ref-type="fig"}). Neuronal knockdown of *Syt7* with two independent RNAi lines (*elav^C155^*-GAL4; UAS-*Syt7* RNAi) dramatically reduced SYT7^RFP^ on western blots ([Figure 11B](#fig11){ref-type="fig"}) and eliminated expression of SYT7^RFP^ at the NMJ ([Figure 11---figure supplement 2](#fig11s2){ref-type="fig"}), indicating the signal is specific to SYT7 and localizes predominantly to the presynaptic compartment.

![Tagging and location of endogenous SYT7.\
(**A**) CRISPR strategy used to insert RFP in frame at the *Syt7* 3'end to generate SYT7^RFP^. Exon coloring is the same as [Figure 1D](#fig1){ref-type="fig"}. The guide RNA cleavage site is displayed in yellow. (**B**) Two *Syt7* UAS-RNAi lines (\#1 and \#2) were used to pan-neuronally knockdown SYT7^RFP^. Western blot analysis of head extracts probed with anti-RFP (top panel) from SYT7^RFP^ adults following pan-neuronal knockdown of SYT7: lane 1: UAS-*Syt7* RNAi\#1; SYT7^RFP^; lane 2: *elav^C155^*-GAL4, UAS-Dicer2; UAS-*Syt7* RNAi\#1; SYT7^RFP^; lane 3: UAS-*Syt7* RNAi\#2; SYT7^RFP^; lane 4: *elav^C155^*-GAL4, UAS-Dicer2; UAS-*Syt7* RNAi line\#2; SYT7^RFP^. SYX1 antisera was used as a loading control (bottom panel). (**C**) Immunocytochemistry with anti-HRP (top) and anti-RFP (bottom) in SYT7^RFP^3^rd^ instar larvae at muscle 6/7 NMJs. SYT7^RFP^ staining is abundant in the presynaptic terminal, with a few postsynaptic membrane compartments also labeled. (**D**) 3D rendering of the terminal bouton (left) from above. The SYT7^RFP^ intra-terminal compartment is labeled in magenta, with HRP-labeled plasma membrane indicated with a grey mesh. Scale bar = 2 µm.](elife-55443-fig11){#fig11}

To further characterize the subsynaptic localization of SYT7, fluorescently-tagged compartmental markers or compartment-specific antisera were used for labeling in the Syt7^RFP^ background. Images were collected on a Zeiss Airyscan and analyzed in FIJI and Matlab to generate cytofluorogram co-localization plots to calculate the Pearson correlation (r) between SYT7^RFP^ and labeled compartments from individual synaptic boutons at muscle 6/7 NMJs ([Figure 12](#fig12){ref-type="fig"}, n = 3 animals each). Co-labeling of the SV proteins nSYB and SYT1 served as a positive control ([Figure 12A](#fig12){ref-type="fig"}, r = 0.71). SYT7^RFP^ and the Golgi marker, Golgin84, served as a negative control since Golgi is absent from presynaptic terminals ([Figure 12L](#fig12){ref-type="fig"}, r = −0.43). Co-localization analysis indicates SYT7 resides on a membrane compartment that does not completely overlap with any protein tested ([Figure 12B--L](#fig12){ref-type="fig"}). The largest overlap was with Dynamin ([Figure 12B](#fig12){ref-type="fig"}, r = 0.22), a GTPase involved in endocytosis that localizes to the peri-AZ. The t-SNARE SYX1 also overlapped with a subset of SYT7 immunolabeling near the plasma membrane ([Figure 12C](#fig12){ref-type="fig"}, r = 0.15). Although SYT7's pattern of inter-connectivity within the bouton appeared similar to peripheral ER, it did not co-localize with Reticulon-like 1 (RTLN1, [Figure 12D](#fig12){ref-type="fig"}, r = 0.01), a peripheral ER marker. In addition, SYT7 did not co-localize with SVs (r = −0.17), DCVs labeled with ANF-GFP (r = −0.07), exosomes (r = −0.19), late endosomes (r = −0.29), lysosomes (r = −0.01) or the plasma membrane (anti-HRP, r = −0.06). Neither SYT7^RFP^ ([Figure 12G](#fig12){ref-type="fig"}, r = −0.11) or SYT7^GFP^ ([Figure 11---figure supplement 1B](#fig11s1){ref-type="fig"}) was enriched at AZs, but instead surrounded BRP as previously described for other peri-AZ proteins. These data are in agreement with anti-SYT7 antibody labeling of sucrose gradient-separated subcellular fractions from wildtype *Drosophila *head extracts that localized SYT7 to a distinct membrane compartment separate from SVs and the plasma membrane ([@bib1]). In conclusion, SYT7 surrounds AZs marked by BRP ([Figure 11---figure supplement 1B](#fig11s1){ref-type="fig"}, [Figure 12G](#fig12){ref-type="fig"}), indicating the protein localizes in part to the previously described peri-AZ domain. Peri-AZs are enriched in proteins regulating SV endocytosis and endosomal trafficking ([@bib28]; [@bib69]; [@bib87]; [@bib111]; [@bib123]), indicating SYT7 may modulate SV re-entry into the RRP by interfacing with sorting machinery within this domain.

![Localization of SYT7 in presynaptic terminals.\
Immunostaining for the indicated proteins in each panel was performed at 3^rd^ instar larval muscle 6/7 NMJs. Staining for all panels except A were done in the SYT7^RFP^ endogenously tagged background using anti-RFP to label the SYT7 compartment, with the merged image shown on the right. The Pearson correlation coefficient (**r**) calculated from the cytofluorogram co-localization plots is shown on the upper right. All images are from single confocal planes. (**A**) Co-localization of the SV proteins SYT1 (left, magenta, anti-SYT1 antisera) and nSYB (middle, green, endogenous nSYB^GFP^) as a positive control. The remaining panels show boutons co-stained for SYT7^RFP^ (left, magenta, anti-RFP antisera) and the indicated compartment marker (middle, green): (**B**) Dynamin (anti-DYN antisera); (**C**) SYX1 (anti-SYX1 antisera); (**D**) Reticulin like-1 (*elav^C155^*-GAL4; UAS-RTNL1-GFP); (**E**) lysosomal Na^+^/H^+^ exchanger 1 (*elav^C155^*-GAL4; UAS-NHE-GFP); (**F**) HRP (anti-HRP antisera); (**G**) BRP (anti-BRP Nc82 antisera); (**H**) nSYB (nSYB^GFP^); (**I**) Atrial natriuretic peptide (*elav^C155^*-GAL4; UAS-ANF-GFP); (**J**) SYT4 (endogenously tagged SYT4^GFP-2M^); (**K**) RAB7 (anti-RAB7 antisera); and (**L**) Golgin84 (anti-GOLGIN84 antisera). Co-localization plots were generated with normalized pixel intensity of stacked images of 10--24 type Ib boutons from three animals per genotype, with the color representing the frequency of data points as shown in the right scale bar. The vertical line on the X-axis indicates the threshold used to identify pixels above background for the compartment stain. The horizontal line on the Y-axis represents the threshold used to identify pixels above background for SYT7. Scale bar = 1 µm.](elife-55443-fig12){#fig12}

SYT7 localization was widespread within the peri-AZ region, with SYT7^RFP^ tubules in close proximity to other labeled membrane compartments, including endosomes, lysosomes, and the plasma membrane ([Figure 12---figure supplement 1](#fig12s1){ref-type="fig"}). To determine if the SYT7 compartment required endosomal trafficking for its assembly or maintenance, a panel of dominant-negative, constitutively-active or wildtype endosomal UAS-RAB proteins ([@bib154]) were expressed with *elav^C155^*-GAL4 in the SYT7^RFP^ background. Manipulations of RAB5 (early endosomes), RAB7 (late endosomes) or RAB4 and RAB11 (recycling endosomes) did not disrupt the abundance or morphology of the SYT7 tubular network ([Figure 12---figure supplement 2](#fig12s2){ref-type="fig"}). Similarly, no change in the distribution of several compartment markers were found in *Syt7^M1^* mutants, including the early endosomal marker RAB5, the late endosomal/peri-AZ marker RAB11 and the peri-AZ protein Nervous Wreck (NWK) ([Figure 12---figure supplement 3](#fig12s3){ref-type="fig"}). In addition, no defect was observed in trans-synaptic transfer of the exosomal protein SYT4 to the postsynaptic compartment, indicating SYT7 does not regulate exosome trafficking as described for several other peri-AZ proteins ([@bib139]). Although no sub-compartment overlapped completely with SYT7, the protein is positioned within the peri-AZ to interact with SVs, endosomes and the recycling machinery to negatively regulate the size of releasable SV pools ([Figure 12---figure supplement 4](#fig12s4){ref-type="fig"}). We conclude that SYT7 does not localize to SVs and is not enriched at AZs, consistent with SYT7 negatively regulating SV release through an indirect mechanism that does not require its presence at sites of SV fusion.

Discussion {#s3}
==========

To characterize the location and function of SYT7 in *Drosophila* we used the CRISPR-Cas9 system to endogenously label the protein and generate null mutations in the *Syt7* locus. Our findings indicate SYT7 acts as a negative regulator of SV release, AZ *P~r~*, RRP size, and RRP refilling. The elevated *P~r~* across the AZ population in *Syt7* mutants provides a robust explanation for why defects in asynchronous release and facilitation are observed in the absence of the protein, as SYT7 levels set the baseline for the amount of evoked release. SYT7's presence on an internal tubular membrane network within the peri-AZ positions the protein to interface with the SV cycle at multiple points to regulate membrane trafficking. In addition, increased SV release in animals lacking both SYT1 and SYT7 indicate the full complement of Ca^2+^ sensors that mediate the distinct phases of SV release remain unknown.

Syt7 mutants have increased *P~r~* at *Drosophila *NMJs {#s3-1}
-------------------------------------------------------

Using a combination of synaptic physiology and imaging approaches, our findings indicate SYT7 acts to reduce SV recruitment and release. Minor defects in asynchronous release and facilitation were identified in *Drosophila Syt7* mutants, as observed in mouse and zebrafish models ([@bib7]; [@bib26]; [@bib59]; [@bib132]; [@bib131]; [@bib142]; [@bib143]). However, we attribute these defects to reduced SV availability as a result of increased *P~r~* in *Syt7* mutants. Indeed, a key feature of facilitation is its critical dependence on initial *P~r~* ([@bib98]; [@bib157]). Low *P~r~* synapses increase SV fusogenicity as Ca^2+^ levels rise during paired-pulses or stimulation trains, resulting in short-term increases in *P~r~* for SVs not recruited during the initial stimuli. In contrast, depression occurs at high *P~r~* synapses due to the rapid depletion of fusion-capable SVs during the initial response. Prior quantal imaging at *Drosophila *NMJs demonstrated facilitation and depression can occur across different AZs within the same neuron, with high *P~r~* AZs depressing and low *P~r~* AZs facilitating ([@bib104]). Given the elevated *P~r~* in *Syt7* mutants, the facilitation defects are likely related to differences in initial *P~r~* and depletion of fusion-competent SVs available for release during the 2^nd^ stimuli.

A similar loss of SVs due to elevated *P~r~* in *Syt7* mutants would reduce fusogenic SVs that are available during the delayed phase of the asynchronous response. *Syt1; Syt7* double mutants continue to show asynchronous fusion and facilitation, demonstrating there must be other Ca^2+^ sensors that mediate these components of SV release. The predominant localization of endogenous SYT7 to an internal tubular membrane compartment at the peri-AZ also places the majority of the protein away from release sites where it would need to reside to directly activate SV fusion. As such, our data indicate SYT7 regulates SV release through a distinct mechanism from SYT1.

We can also conclude that the remaining components of asynchronous fusion and facilitation must be mediated by an entirely different family of Ca^2+^-binding proteins than Synaptotagmins (or through Ca^2+^-lipid interactions). Of the seven *Syt* genes in the *Drosophila *genome, only 3 SYT proteins are expressed at the motor neuron synapses assayed in our study -- SYT1, SYT4 and SYT7 ([@bib1]). For the remaining SYTs in the genome, SYT-α and SYT-β are expressed in neurosecretory neurons and function in DCV fusion ([@bib1]; [@bib103]). SYT12 and SYT14 lack Ca^2+^ binding residues in their C2 domains and are not expressed in motor neurons ([@bib1]). In addition, SYT4 is found on exosomes and transferred to postsynaptic cells, where it participates in retrograde signaling ([@bib1]; [@bib52]; [@bib70]; [@bib139]; [@bib149]). *Syt1; Syt4* double mutants display the same SV fusion defects found in *Syt1* mutants alone, indicating SYT4 cannot compensate for SYT1 function in SV release ([@bib9]; [@bib116]). As such, SYT1 and SYT7 are the only remaining SYT isoforms that could contribute to SV trafficking within *Drosophila *motor neuron terminals.

A prior study from our lab using a *Syt7* exon-intron hairpin RNAi we generated did not result in an increase in evoked release ([@bib116]). Although a reduction in ectopic expression of SYT7 in muscles could be seen with *Mhc*-GAL4 driving the UAS-*Syt7* RNAi, our anti-SYT7 antisera does not recognize the endogenous protein in neurons using immunocytochemistry, preventing a determination of presynaptic SYT7 levels following neuronal RNAi. To further examine this issue, we performed western blot analysis with this RNAi and compared it those used in the current study. Our results confirmed that the RNAi line failed to reduce endogenous GFP-tagged SYT7 (data not shown), although the two commercial RNAi lines we used here were highly effective ([Figure 11B](#fig11){ref-type="fig"}). Based on these data, we conclude that the previous *Syt7* UAS-RNAi line was ineffective in knocking down endogenous SYT7. Given the *Syt7^M1^* and *Syt7^M2^* alleles result in early stop codons and lack SYT7 expression by western blot analysis and display elevated levels of fusion, our data indicate SYT7 normally acts to suppress SV release as demonstrated by electrophysiology and optical *P~r~* imaging. SYT7 overexpression reduces SV release even more, further confirming that the levels of SYT7 set the baseline amount of SV fusion at *Drosophila *NMJ synapses.

SYT7 regulates the recruitment and fusion of SVs in a dose-dependent manner {#s3-2}
---------------------------------------------------------------------------

Although our data indicate SYT7 is not the primary asynchronous or facilitation Ca^2+^ sensor in *Drosophila,* we found it inhibits SV release in a dosage-sensitive manner. The reduction in SV release is not due to changes in the Ca^2+^ cooperativity of fusion or enhanced presynaptic Ca^2+^ entry, ruling out the possibility that SYT7 normally acts as a local Ca^2+^ buffer or an inhibitor of presynaptic voltage-gated Ca^2+^ channels. The reduction in release is also not due to altered endocytosis, as *Syt7* mutants have a normal steady-state rate of SV cycling following depletion of the RRP. Instead, SYT7 regulates SV fusogenicity at a stage between SV endocytosis and fusion. Given the rapid enhanced refilling of the RRP observed in *Syt7* mutants, and the suppression of RRP refilling following SYT7 overexpression, our data indicate SYT7 regulates releasable SVs in part through changes in SV mobilization to the RRP. Ca^2+^ is well known to control the replenishment rate of releasable SVs, with Calmodulin-UNC13 identified as one of several molecular pathways that accelerate RRP refilling in a Ca^2+^-dependent manner ([@bib35]; [@bib36]; [@bib63]; [@bib75]; [@bib110]). Our findings indicate SYT7 acts in an opposite fashion and slows RRP refilling, providing a Ca^2+^-dependent counter-balance for SV recruitment into the RRP. Although such an effect has not been described for mammalian SYT7, defects in RRP replenishment have been observed when both SYT1 and SYT7 are deleted or following high frequency stimulation trains ([@bib8]; [@bib38]; [@bib80]).

SYT7's role in restricting SV fusion and RRP size also affects spontaneous release. Although *Syt7* mutants alone do not show elevated mini frequency, *Double^Null^* mutants have a 2-fold increase in spontaneous release. Similar increases in spontaneous release were observed at mammalian synapses lacking both SYT7 and SYT1 (or SYT2), with the effect being attributed to a dual role in clamping fusion in the absence of Ca^2+^ ([@bib84]; [@bib132]). Our results indicate the elevation in spontaneous release at *Drosophila *synapses is a result of an increase in releasable SVs rather than a clamping function for SYT7. Following overexpression of SYT7, there is a reduction in the number of fusogenic SVs available for both evoked and spontaneous release. The dosage-sensitivity of the various phenotypes indicate SYT7 abundance is a critical node in controlling SV release rate. Indeed, mammalian SYT7 levels are post-transcriptionally modulated by γ-secretase proteolytic activity and APP, linking it to SV trafficking defects in Alzheimer's disease ([@bib10]).

How does SYT7 negatively regulate recruitment and fusion of SVs? {#s3-3}
----------------------------------------------------------------

The precise mechanism by which SYT7 reduces release and slows refilling of the RRP is uncertain given it is not enriched at sites of SV fusion. Although we cannot rule out the possibility that a small fraction of the protein is found at AZs, SYT7 is predominantly localized to an internal membrane compartment at the peri-AZ where SV endocytosis and endosomal sorting occurs ([@bib28]; [@bib69]; [@bib87]; [@bib111]; [@bib123]). SYT7 membrane tubules are in close proximity and could potentially interact with peri-AZs proteins, endosomes, lysosomes and the plasma membrane. Given its primary biochemical activity is to bind membranes in a Ca^2+^-dependent manner, SYT7 could mediate cargo or lipid movement across multiple compartments within peri-AZs. In addition, it is possible SYT7 tubules could form part of the poorly defined SV recycling endosome compartment. However, we observed no change in SV density or SV localization around AZs, making it unlikely SYT7 would be essential for endosomal trafficking of SVs. The best characterized regulator of the SV endosome compartment in *Drosophila *is the RAB35 GAP Skywalker (SKY) ([@bib134]). Although *Sky* mutations display some similarities to *Syt7*, including increased neurotransmitter release and larger RRP size, *Syt7* lacks most of the well-described *Sky* phenotypes such as behavioral paralysis, FM1-43 uptake into discrete punctated compartments, cisternal accumulation within terminals and reduced SV density. In addition, we found no co-localization between SKY-GFP and SYT7^RFP^ within presynaptic terminals.

By blocking SV refilling with bafilomycin, our findings indicate the fast recovery of the RRP can occur via enhanced recruitment from the reserve pool and does not require changes in endocytosis rate. The phosphoprotein Synapsin has been found to maintain the reserve SV pool by tethering vesicles to actin filaments at rest ([@bib4]; [@bib19]; [@bib55]; [@bib94]; [@bib121]). Synapsin interacts with the peri-AZ protein Dap160/Intersectin to form a protein network within the peri-AZ that regulates clustering and release of SVs ([@bib46]; [@bib87]; [@bib144]). Synapsin-mediated phase separation is also implicated in clustering SVs near release sites ([@bib93]; [@bib94]). SYT7 could similarly maintain a subset of SVs in a non-releasable pool and provide a dual mechanism for modulating SV mobilization. Phosphorylation of Synapsin and Ca^2+^ activation of SYT7 would allow multiple activity-dependent signals to regulate SV entry into the RRP. As such, SYT7 could play a key role in organizing membrane trafficking and protein interactions within the peri-AZ network by adding a Ca^2+^-dependent regulator of SV recruitment and fusogenicity.

Additional support for a role for SYT7 in regulating SV availability through differential SV sorting comes from recent studies on the SNARE complex binding protein CPX. Analysis of *Drosophila Cpx* mutants, which have a dramatic increase in minis ([@bib18]; [@bib57]; [@bib62]), revealed a segregation of recycling pathways for SVs undergoing spontaneous versus evoked fusion ([@bib115]). Under conditions where intracellular Ca^2+^ is low and SYT7 is not activated, spontaneously-released SVs do not transit to the reserve pool and rapidly return to the AZ for re-release. In contrast, SVs released during high frequency evoked stimulation when Ca^2+^ is elevated and SYT7 is engaged, re-enter the RRP at a much slower rate. This mechanism slows re-entry of SVs back into the releasable pool when stimulation rates are high and large numbers of SV proteins are deposited onto the plasma membrane at the same time, allowing time for endosomal sorting that might be required in these conditions. In contrast, SVs released during spontaneous fusion or at low stimulation rates would likely have less need for endosomal re-sorting. Given SYT7 restricts SV transit into the RRP, it provides an activity-regulated Ca^2+^-triggered switch for redirecting and retaining SVs in a non-fusogenic pool that could facilitate sorting mechanisms.

Beyond SV fusion, presynaptic membrane trafficking is required for multiple signaling pathways important for developmental maturation of NMJs ([@bib53]; [@bib90]; [@bib100]; [@bib107]; [@bib112]). In addition, alterations in neuronal activity or SV endocytosis can result in synaptic undergrowth or overgrowth ([@bib3]; [@bib17]; [@bib34]; [@bib49]; [@bib69]). We did not find any defect in synaptic bouton or AZ number, indicating SYT7 does not participate in membrane trafficking pathways that regulate synaptic growth and maturation. However, a decrease in T-bar area and presynaptic Ca^2+^ influx in *Syt7* mutants was found. Although it is unclear how these phenotype arise, they may represent a form of homeostatic plasticity downstream of elevated synaptic transmission ([@bib43]). There is also ample evidence that SV distance to Ca^2+^ channels plays a key role in defining the kinetics of SV release and the size of the RRP ([@bib14]; [@bib25]; [@bib97]; [@bib98]; [@bib137]), suggesting a change in such coupling in *Syt7* mutants might contribute to elevations in *P~r~* and RRP refilling. Further studies will be required to precisely define how SYT7 controls the baseline level of SV release at synapses.

Materials and methods {#s4}
=====================

*Drosophila* stocks {#s4-1}
-------------------

*Drosophila melanogaster* were cultured on standard medium at 22--25°C. Genotypes used in the study include: *elav^C155^*-GAL4 (Bloomington *Drosophila *Stock Center (BDSC)\#8765), UAS-ANF-Emerald (BDSC\#7001), SYT4^GFP-2M^ ([@bib52]), *Syt1^AD4^* ([@bib33]), *Syt1^N13^* ([@bib77]), UAS-*Syt7* ([@bib116]), *Mhc*-GAL4 (BDSC\#55132), UAS-Syt7 RNAi\#1 (Vienna\#24989) and UAS-Syt7 RNAi\#2 (BDSC\#27279). Lines used for testing co-localization with SYT7^RFP^ or mis-localization in Syt7^M1^ include: endogenous nSYB^GFP^ (this study), UAS-NHE-GFP (this study), UAS-ANF-Emerald (BDSC\#7001), SYT4^GFP-2M^ ([@bib52]), UAS-RTNL1-GFP (BDSC\#77908), RAB5-YFP (BDSC\#62543) and RAB11-YFP (BDSC\#62549). Lines used for assaying SYT7^RFP^ localization after overexpressing RABs: UAS-RAB4-YFP (BDSC\#9767), UAS-RAB4(Q67L)-YFP (BDSC\#9770), UAS-RAB5-YFP (BDSC\#24616), UAS-RAB5(S43N)-YFP (BDSC\#9772), UAS-RAB5(T22N)-YFP (BDSC\#9778), UAS-RAB7-YFP (BDSC\#23641), UAS-RAB7(Q67L)-YFP (BDSC\#9779), UAS-RAB11-YFP (BDSC\#50782) and UAS-RAB11(S25N)-YFP (BDSC\#9792) ([@bib154]).

Genome engineering of Syt7^M1^ mutant and SYT7^RFP^ knock-in {#s4-2}
------------------------------------------------------------

Guide RNAs were selected using the CRISPR Optimal Target Finder resource ([@bib48]) and cloned into the plasmid pCFD4-U6:1_U6:3tandemgRNAs (Addgene \#49411) ([@bib108]). To generate *Syt7^M1^*, guide RNA containing pCFD4 plasmid was inject into *vasa*-Cas9 embryos (BDSC \#56552) by Best Gene Inc (Chino Hills, CA, USA). *Syt7^M1^* and an unaffected injection line (control) were brought into the *white* background and the *vasa*-Cas9 chromosome was removed. To generate SYT7^RFP^, a donor plasmid that flanked RFP and a DsRed cassette was generated from the pScarless plasmid (courtesy of Kate O'Connor-Giles) with 1 Kb homology arms from the 3' end of the *Syt7* gene. The left homology arm was generated by PCR and the right homology arm was synthesized by Epoch Life Science (Sugarland, TX, USA). The donor plasmid and guide RNA containing pCFD4 plasmid was co-injected into Act5C-Cas9, Lig4 (BDSC \#58492) by Best Gene Inc *Syt7^M1^* and SYT7^RFP^ transformants were confirmed by DNA sequencing.

Sequence alignment, phylogenetic tree construction and molecular modeling {#s4-3}
-------------------------------------------------------------------------

NCBI BLAST was used to identify homologs of SYT1, SYT7 and ESYT-2 in the genomes of *C. elegans*, *C. intestinalis*, *D. rerio*, *M. musculus*, *H. sapiens*, *R. norvegicus* and *T. adherens*. Jalview was used to align SYT1 and SYT7 protein sequences from *D. melanogaster*, *M. Musculus* and *H. sapiens* with the T-coffee multiple sequence alignment algorithm. Jalview and Matlab were used to generate a phylogenetic tree using BLOSUM62 matrix and neighbor joining clustering. The SWISS model server (<https://swissmodel.expasy.org>) was used for homology modeling of *Drosophila *SYT7 from *R. norvegicus* SYT7 (PBD: 6ANK) ([@bib141]). The PyMOL Molecular Graphics System (Version 2.0 Schrödinger, LLC) was used to visualize SYT1 and SYT7 protein structures.

Sequences used for sequence alignment and phylogenetic treeProteinSpeciesNCBI accession numberESYT2*C. elegans*NP_741181.1*C. intestinalis*XP_018671537.1*D. melanogaster*NP_733011.2*D. rerio*XP_005171456.1*H. sapiens*XP_024302614.1*R. norvegicus*NP_001258098.1*T. adhaerens*EDV19885.1SYT1*C. elegans*NP_495394.3*C. intestinalis*NP_001107602.1*D. melanogaster*NP_523460.2*D. rerio*NP_001314758.1*H. sapiens*NP_001129277.1*R. norvegicus*NP_001028852.2*T. adhaerens*XP_002117742.1SYT7*C. elegans*NP_001254022.1*C. intestinalis*XP_026696415.1*D. melanogaster*NP_726560.5*D. rerio*XP_021326273.1*H. sapiens*NP_004191.2*R. norvegicus*NP_067691.1*T. adhaerens*XP_002117784.1

Western blot analysis and immunocytochemistry {#s4-4}
---------------------------------------------

Western blotting of adult head lysates (one head/lane) was performed using standard laboratory procedures with anti-SYT7 (1:500) ([@bib1]), anti-SYX1 (8C3, 1:1000, Developmental Studies Hybridoma Bank (DSHB, Iowa City, IA) and anti-RFP (600-401-379; Rockland, 1:5000). Visualization and quantification were performed with a LI-COR Odyssey Imaging System (LI-COR Biosciences, Lincoln, MA, USA). Secondary antibodies for western blotting included Alexa Fluor 680-conjugated goat anti-rabbit IgG (1:5000, Invitrogen; A21109) and IR Dye 800-conjugated goat anti-mouse IgG (1:5000, LICOR; 926--32211).

Immunostaining for AZ and bouton counting was performed on wandering stage 3rd instar larvae dissected in Ca^2+^-free HL3.1 and fixed for 17 min in Ca^2+^-free HL3.1 containing 4% PFA. Larvae were blocked and permeabilized for 1 hr in PBS containing 0.1% Triton X-100, 2.5% NGS, 2.5% BSA and 0.1% sodium azide. Larvae were incubated overnight with primary antibody at 4°C and 2 hr in secondary antibody at room temperature. Samples were mounted on slides with Vectashield (Vector Laboratories, Burlingame, CA). Immunostaining for SYT7^RFP^ and STY7^GFP^ co-localization analysis was similar, except larvae were blocked and permeabilized overnight in PBS containing 0.25% Saponin, 2.5% normal goat serum (NGS), 2.5% bovine serum albumin (BSA) and 0.1% sodium azide. Fixed larvae were incubated with primary antibody at 4°C for 24 hr and with secondary antibodies for 1.5 hr at room temperature. Fixed larvae were mounted in ProLong Diamond Antifade Mountant (\#P36970; Thermo Fisher Scientific, Waltham, MA, USA).

Antibodies used for immunolabeling were: mouse anti-BRP at 1:500 (Nc82; DSHB), mouse anti-DYN at 1:1000 (Clone 41, Dynamin (RUO); BD Transduction Laboratories, San Jose, CA, USA), mouse anti-Golgin84 at 1:50 (Golgin84 12--1; DSHB), mouse anti-RAB7 at 1:10 (Rab7; DSHB), mouse anti-RFP at 1:1000 (200-301-379; Rockland, Limerick, PA, USA) mouse anti-SYX1 at 1:100 (8C3; DSHB), rabbit anti-CPX at 1:5000 ([@bib57]), rabbit anti-NWK at 1:1000 (gift from Avital Rodal), rabbit anti-SYT1 1:500, mouse anti-GFP at 1:1000 (\#A-11120; Thermo Fisher Scientific, Waltham, MA, USA), rabbit anti-GFP at 1:1000 (\#G10362; Thermo Fisher Scientific, Waltham, MA, USA), mouse anti-RFP at 1:1000 (200-301-379; Rockland), rabbit anti-RFP at 1:1000 (600-401-379; Rockland) and DyLight 649 conjugated anti-HRP at 1:1000 (\#123-605-021; Jackson Immuno Research, West Grove, PA, USA). Secondary antibodies used for AZ and bouton counting were used at 1:1000: goat anti-rabbit Alexa Flour 488-conjugated antibody (A-11008; Thermofisher) and goat anti-mouse Alexa Fluor 546-conjugated antibody (A-11030; ThermoFisher). Secondary antibodies used for co-localization were used at 1:1000: goat anti-mouse Alexa Fluor Plus 555 (A32727; Thermofisher), goat anti-mouse Alexa Fluor Plus 488 (A32723; ThermoFisher), goat anti-rabbit Alexa Fluor Plus 555 (A32732; ThermoFisher) and goat anti-rabbit Alexa Fluor Plus 488 (A32731; ThermoFisher).

Immunoreactive proteins were imaged on either a Zeiss Pascal Confocal (Carl Zeiss Microscopy, Jena, GERMANY) using a 40x or 63X NA 1.3 Plan Neofluar oil immersion objective or a ZEISS LSM 800 microscope with Airyscan using a 63X oil immersion objective. For AZ volume and AZ proximity measurements, samples were imaged on a Zeiss Airyscan microscope and BRP labeling was analyzed in Volocity 6.3.1 software (Quorum Technologies Inc, Puslinch, Ontario, CAN). AZs clusters larger than 0.2 µm^3^ were rarely found, but could not be resolved into single objects by the software. To ensure such clusters did not affect AZ size analysis, all AZs larger than 0.2 µm^3^ were excluded from the analysis.

Electrophysiology {#s4-5}
-----------------

Postsynaptic currents from the indicated genotypes were recorded from 3^rd^ instar muscle fiber 6 at segment A3 using two-electrode voltage clamp with a −80 mV holding potential in HL3.1 saline solution (in mM, 70 NaCl, 5 KCl, 10 NaHCO3, 4 MgCl2, five trehalose, 115 sucrose, 5 HEPES, pH 7.2) as previously described ([@bib62]). Final \[Ca^2+^\] was adjusted to the level indicated in the text. The Ca^2+^ cooperativity of release was determined from the slopes of a linear fit of a double logarithmic plot of evoked responses in the linear range (0.175 to 0.4 mM Ca^2+^). Inward currents recorded during TEVC are labeled as positive values in the figures for simplicity. For experiments using bafilomycin, 4 µm bafilomycin (LC Laboratories, Woburn, MA, USA) was dissolved in dimethyl sulphoxide (DMSO, Sigma, St. Louis, MO, USA) in HL3.1 and bath applied to dissected larvae. DMSO containing HL3.1 was used for control. Data acquisition and analysis was performed using Axoscope 9.0 and Clampfit 9.0 software (Molecular Devices, Sunnyvale, CA, USA). mEJCs were analyzed with Mini Analysis software 6.0.3 (Synaptosoft, Decatur, GA, USA). Motor nerves innervating the musculature were severed and placed into a suction electrode. Action potential stimulation was applied at the indicated frequencies using a programmable stimulator (Master8, AMPI; Jerusalem, Israel).

Fluo-4 AM imaging {#s4-6}
-----------------

Fluo-4 AM (F14201; ThermoFisher) loading was performed as previously described ([@bib31]). During incubation, neuronal membranes were labeled with DyLight 649 conjugated anti-HRP at 1:1000 (\#123-605-021; Jackson Immuno Research, West Grove, PA, USA). NMJs of Ib motoneurons at muscle 6/7 were identified and motor nerves were stimulated in HL3 saline with 20 mM MgCl~2~ and 1.1 mM Ca^2+^ for 5 s at 10 Hz for three epochs, each with a 5 s rest period between stimulation. Imaging of Fluo-4 AM fluorescent signal was performed on a Zeiss Axio Imager two equipped with a spinning-disk confocal head (CSU-X1; Yokagawa, JAPAN) and ImagEM X2 EM-CCD camera (Hamamatsu, Hamamatsu City JAPAN). 5 µm stacks from synaptic boutons were imaged at a frame rate of 1.25 Hz and mean Fluo-4 AM fluorescent intensity was determined during the stimulation protocol for each trial.

Optical quantal imaging and P~r~ mapping {#s4-7}
----------------------------------------

*P~r~* mapping was performed on a Zeiss Axio Imager equipped with a spinning-disk confocal head (CSU-X1; Yokagawa, JAPAN) and ImagEM X2 EM-CCD camera (Hamamatsu, Hamamatsu City JAPAN) as previously described ([@bib3]). Myristoylated-GCaMP6s was expressed in larval muscles with 44H10-LexAp65 (provided by Gerald Rubin). Individual PSDs were visualized by expression of GluRIIA-RFP under its endogenous promoter (provided by Stephan Sigrist). An Olympus LUMFL N 60X objective with a 1.10 NA was used to acquire GCaMP6s imaging data at 8 Hz. 3^rd^ instar larvae were dissected in Ca^2+^-free HL3 containing 20 mM MgCl~2~. After dissection, preparations were maintained in HL3 with 20 mM MgCl~2~ and 1.0 mM Ca^2+^ for 5 min. A dual channel multiplane stack was imaged at the beginning of each experiment to identify GluRIIA-positive PSDs. Single focal plane videos were then recorded while motor nerves were stimulated with a suction electrode at 1 Hz. GluRIIA-RFP PSD position was re-imaged every 25 s during experiments. The dual channel stack was merged with single plane images using the max intensity projection algorithm from Volocity 6.3.1 software. The position of all GluRIIA-RFP PSDs was then spliced with the myr-GCaMP6s stimulation video. GluRIIA positive PSDs were detected automatically using the spot finding function of Volocity and equal size ROIs were assigned to the PSD population. In cases where the software failed to label visible GluRIIA-RFP PSDs, ROIs were added manually. GCaMP6s peak flashes were then detected and assigned to ROIs based on centroid proximity. The time and location of Ca^2+^ events were imported into Excel or Matlab for further analysis. Observed GCaMP events per ROI were divided by stimulation number to calculate AZ *P~r~*.

FM1-43 uptake and release assays {#s4-8}
--------------------------------

3^rd^ instar wandering larvae were dissected in Ca^2+^-free HL3.1 and axons were severed from the CNS. Axon bundles were stimulated with a suction electrode in 1.5 mM CaCl~2~ HL3.1 solution containing 2 µM of the lipophilic dye FM 1-43FX (F35355; Thermo Fisher Scientific, Waltham, MA, USA). Dye loading was performed at 10 Hz for 50 s (500 events) or at 0.5 Hz for 300 s (150 events), 600 s (300 events) and 900 s (600 events) as indicated. After stimulation, samples were washed for 2 min in Ca^2+^ free HL3.1 containing 100 µM Advacep-7 (Sigma; A3723) to help remove non-internalized FM 1--43 dye. Image stacks from muscle 6/7 at segment A3 were obtained using a spinning disk confocal microscope. FM1-43 unloading was done with a high K^+^ (90 mM) HL3.1 solution for 1 min, followed by washing in a Ca^2+^ free HL3.1 solution for 1 min. An image stack at segment A3 muscle 6--7 was obtained on a Zeiss Axio Imager two equipped with a spinning-disk confocal head with a 63X water immersion objective. Mean FM1-43 intensity at the NMJ was quantified using the Volocity 3D Image Analysis software (Quorum Technologies Inc, Puslinch, Ontario, CAN).

Electron microscopy {#s4-9}
-------------------

*Syt1^M1^* and control 3^rd^ instar larvae were dissected in Ca^2+^-free HL3.1 solution and fixed in 1% glutaraldehyde, 4% formaldehyde, and 0.1 m sodium cacodylate for 10 min at room temperature as previously described ([@bib5]). Fresh fixative was added and samples were microwaved in a BioWave Pro Pelco (Ted Pella, Inc, Redding, CA, USA) with the following protocol: (1) 100W 1 min, (2) 1 min off, (3) 100W 1 min, (4) 300W 20 secs, (5) 20 secs off, (6) 300W 20 secs. Steps 4--6 were repeated twice more. Samples were then incubated for 30 min at room temperature with fixative. After washing in 0.1 M sodium cacodylate and 0.1 M sucrose, samples were stained for 30 min in 1% osmium tetroxide and 1.5% potassium ferrocyanide in 0.1 M sodium cacodylate solution. After washing with 0.1 M sodium cacodylate, samples were stained for 30 mins in 2% uranyl acetate and dehydrated through a graded series of ethanol and acetone, before embedding in epoxy resin (Embed 812; Electron Microscopy Sciences). Thin sections (50--60 nm) were collected on Formvar/carbon-coated copper slot grids and contrasted with lead citrate. Sections were imaged at 49,000 × magnification at 80 kV with a Tecnai G2 electron microscope (FEI, Hillsboro, OR, USA) equipped with a charge-coupled device camera (Advanced Microscopy Techniques, Woburn, MA, USA). Type Ib boutons at muscle 6/7 were analyzed. All data analyses were done blinded.

For SV counting, T-bars at Ib boutons were identified and a FIJI macro was used to draw four concentric circles with 100 nm, 200 nm, 300 nm or 400 nm radius. The concentric circles were drawn with the T-bar at the center. To quantify vesicle density, FIJI was used to measure the area of the bouton and quantify the total number of vesicles within it. Final analysis was performed in Matlab and Excel.

Co-localization analysis and 3D reconstruction {#s4-10}
----------------------------------------------

The JaCOP FIJI algorithm ([@bib15]) was used to obtain cytofluorogram plots of bouton image stacks that were probed for RFP and a 2^nd^ labeled compartment in SYT7^RFP^3^rd^ instar larvae. Automatic thresholding was used to identify pixels above background for both channels. To obtain an average Pearson correlation, cytofluorograms from boutons obtained from three animals were analyzed in Matlab. All data analyseis were done blinded. 3D reconstruction was performed using the 3D Viewer plugin in FIJI ([@bib117]). The bouton stack was displayed as a surface and labeled with SYT7^RFP^ in magenta and HRP in black.

Statistical analysis {#s4-11}
--------------------

Statistical analysis and graphing was performed with either Origin Software (OriginLab Corporation, Northampton, MA, USA) or GraphPad Prism (San Diego, CA, USA). Statistical signiﬁcance was determined using specific tests as indicated in the text. Appropriate sample size was determined using GraphPad Statmate. Asterisks denote p-values of: \*, p≤0.05; \*\*, p≤0.01; and \*\*\*, p≤0.001. All histograms and measurements are shown as mean ± SEM.
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**Acceptance summary:**

Synaptotagmin 7 has been implicated as a calcium sensor involved in the short-term dynamics of neurotransmitter release at synapses throughout the mammalian central nervous system. This paper from the laboratory of Dr. Troy Littleton examines the function of Synaptotagmin 7 at a well characterized invertebrate synapse, the *Drosophila* NMJ, where high resolution quantification of neurotransmitter release characteristics can be combined with routine imaging and electron microscopy. The authors provide evidence that Synaptotagmin 7 negatively regulates baseline neurotransmitter release, a distinct function compared to existing studies, and an important addition to the field of synaptic vesicle fusion and synaptic transmission.

**Decision letter after peer review:**

Thank you for submitting your article \"*Drosophila* Synaptotagmin 7 negatively regulates synaptic vesicle fusion and replenishment in a dosage-dependent manner\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Gary Westbrook as the Senior Editor. The reviewers have opted to remain anonymous.

Summary

Guan et al. examine the role of Synaptotagmin 7 (*Syt7*) in synaptic transmission at the larval *Drosophila* NMJ. This is an interesting topic, and the field is currently focused on the possibility that *Syt7* is a calcium sensor responsible for the short-term dynamics of neurotransmitter release, although there are other models currently being debated in the literature. In the present study, electrophysiological analysis of newly generated *Syt7* null mutants revealed a pronounced (\~2-fold) increase in neurotransmitter release in heterozygous and homozygous *Syt7* mutants. Conversely, neural *Syt7* overexpression decreased release. *Syt7* mutants display higher release probability, decreased short-term facilitation, increased RRP size and faster recovery from synaptic depression. Release of *Syt7*/*Syt1* double mutants was larger than in *Syt1* mutants alone, implying that *Syt7* negatively regulates release independent of *Syt1*. Changes in synaptic physiology did not correlate with apparent changes in synaptic morphology or ultrastructure. Endogenously tagged *Syt7* localizes to synaptic boutons, where it does not co-localize with several markers, including the active zone marker Bruchpilot. Based on these data, the authors propose a model in which *Syt7* negatively regulates the release and resupply of synaptic vesicles. In general, the study is based on a considerable amount of solid data and the major phenotype is interesting, as it implies a new role for *Syt7* in negative release regulation that differs from previous findings in different species.

Three reviewers with detailed knowledge of the mechanisms of neurotransmitter release and genetic analyses in model organisms examined and discussed the paper. There was considerable discussion about the major conclusions of the study. The reviewers generally agree on a set of major deficits. As the authors can see below, there was also considerable debate regarding more extensive experiments that would substantially strengthen the work, but which were ultimately deemed un-necessary at this time. Thus, the focus on the major experimental requirements reflects both a need for new data/analysis and careful consideration by the reviewers as to the experiments that are essential versus experiments that would simply extend impact. Regarding the major experiments requested:

First, there was discussion as to whether or not the current data fully refute existing models of *Syt7* function. In this regard, there is a notable absence of data to directly interrogate the calcium-dependence of neurotransmission. These experiments are straightforward and do not necessitate additional resources and would greatly strengthen the study, regardless of outcome.

Second, the reviewers discussed the need for genetic rescue. It is clear from the literature that tagged SYT proteins can interrupt normal trafficking. Given that tagged over-expression constructs are the major source of information for the peri-active zone model of *Syt7* function in *Drosophila*, additional genetic experiments are essential in order to demonstrate genetic rescue and substantiate the use of the tagged transgenes. Again, no new reagents are necessary, and the experiments are straightforward with time necessary only for several generations of crosses, which should take less than the 2-3 month interval in total and necessitate time investment at the end for analysis.

Third, there is a notable discrepancy with work previously published by the Littleton laboratory regarding *Syt7* function. In essence, an analysis was previously published for a mutation that was shown to eliminate *Syt7* function, and no functional phenotype was documented electrophysiologically. This discrepancy needs to be resolved. These and a few additional major issues are detailed below with additional specificity.

Major Issues:

1\) As discussed by the authors, it remains completely elusive why loss of *Syt7* results in increased release. While this, in itself, is not necessarily a problem, there are missing experiments that are straightforward tests of the existing models that should be performed in order for this study to move the field forward sufficiently to justify publication in a general topic, high profile journal such as e*Life*. These include: A) test of calcium-dependence of release over a wide range of calcium concentrations (0.2-2mM) performed in voltage clamp. B) Direct measurement of presynaptic, action-potential induced calcium influx. This is the most labor-intensive experiment requested, but one that is deemed essential given the existing literature and given that *Syt7* is a calcium-binding protein. This experiment is well within the expertise of the Littleton laboratory given their elegant analyses of postsynaptic calcium dynamics. With respect to the necessary nature of these experiments, one reviewer wrote, \"Of particular interest, Liu et al., 2014 (Chapman lab) concluded (using cultured hippocampal neurons from *Syt7* KO mice) that *Syt7* is the calcium sensor for SV replenishment during high frequency stimulation. Removal of *Syt7* had no effect on the basal RRP but significantly slowed recruitment of SVs to the RRP during high frequency stimulation and this function depended on its ability to bind calcium. This stands in direct contrast to the results shown here. Without the addition of clear data probing calcium influx presynaptically, and without additional data on the calcium-dependence of release and vesicle coupling, the present study fails to directly or adequately address the other major hypothesis in the field.\"

2\) The authors put forward an interesting new model for *Syt7* function that is based on anatomical localization of the *Syt7* protein at the NMJ. In order to validate this model, it is essential that the tagged protein be shown to function correctly. Therefore, the authors should demonstrate that the tagged constructs achieve full rescue of the null mutation.

3\) Related to point number 2, the authors should shore up the genetic argument that *Syt7* is dose dependent. The authors should include genetic rescue to confirm the nature of the mutations. Furthermore, the authors should place their putative null mutation in trans to a deletion of the gene locus to demonstrate, unequivocally, that the null is a clear loss of function mutation. This is particularly important given that release is enhanced in the loss of function mutant background.

4\) Control EJC amplitudes in Figure 3 (showing the reduction in the OE condition) are equivalent to the experimental amplitudes in Figure 2 (reporting an increase in the mutant). In other words, the authors must explain why the controls are not consistent, and why the effects in one experiment are no different than the controls in another. If these are differences in genetic background, then this should be clearly stated and supported by the inclusion of additional data, possibly in a supplemental figure. Alternatively, there may be a need for additional experiments to clarify this discrepancy.

5\) The authors need to come to directly address their own previously published data. In the (Sarawati et al., 2007) paper they demonstrate complete elimination of *Syt7* protein at the NMJ using RNAi. However, the EPSP amplitudes at 0.1 and 0.4mM external calcium are identical to controls. This is not the phenotype that they currently present. The field will not be able to make a judgment regarding the correct answer. The Littleton lab must have thought about this issue and is the only laboratory that is able to make sense of the discrepancy. The current paper should not be published without adequate resolution of this issue, either with clear new text added to the manuscript or with experimentation.

6\) Figure 2A, 3A, and 7B: The noise of the average mEJC traces is (almost perfectly) correlated between genotypes. How were these average traces computed? How can (regular) noise be correlated between different recordings/experimental groups? Was a noise cancelling device utilized? If so, the authors need to address how this affects amplitude and kinetic measurements and state in methods. Alternative explanations?

7\) The title implies that *Syt7* regulates synaptic fusion. However, the study does not provide direct evidence that *Syt7* negatively regulates the fusion process. I therefore suggest changing the title accordingly.

10.7554/eLife.55443.sa2

Author response

> Major Issues:
>
> 1\) As discussed by the authors, it remains completely elusive why loss of Syt7 results in increased release. While this, in itself, is not necessarily a problem, there are missing experiments that are straightforward tests of the existing models that should be performed in order for this study to move the field forward sufficiently to justify publication in a general topic, high profile journal such as eLife. These include: A) test of calcium-dependence of release over a wide range of calcium concentrations (0.2-2mM) performed in voltage clamp. B) Direct measurement of presynaptic, action-potential induced calcium influx. This is the most labor-intensive experiment requested, but one that is deemed essential given the existing literature and given that Syt7 is a calcium-binding protein. This experiment is well within the expertise of the Littleton laboratory given their elegant analyses of postsynaptic calcium dynamics. With respect to the necessary nature of these experiments, one reviewer wrote, \"Of particular interest, Liu et al., 2014 (Chapman lab) concluded (using cultured hippocampal neurons from Syt7 KO mice) that Syt7 is the calcium sensor for SV replenishment during high frequency stimulation. Removal of Syt7 had no effect on the basal RRP but significantly slowed recruitment of SVs to the RRP during high frequency stimulation and this function depended on its ability to bind calcium. This stands in direct contrast to the results shown here. Without the addition of clear data probing calcium influx presynaptically, and without additional data on the calcium-dependence of release and vesicle coupling, the present study fails to directly or adequately address the other major hypothesis in the field.\"

These are excellent suggestions for expanding our study and represent experiments that we had completed before the coronavirus-mandated closure of research labs by MIT. We present the results of these two major experiments in the revised manuscript. Together, they have allowed us to further define the mechanisms contributing to the enhanced evoked release observed in *Syt7* mutants.

For requested experiment A, we performed TEVC recordings in control and *Syt7^M1^*nulls in eight extracellular Ca^2+^concentrations: 0.175, 0.2, 0.3, 0.4, 0.6, 0.8, 1, and 2 mM. The slopes from a linear fit of a double logarithmic plot of evoked responses in the linear range was used to determine the Ca^2+^cooperativity of release. This data is now included as new panel L in Figure 2. *Syt7^M1^*mutants display enhanced evoked release over the entire range of extracellular Ca^2+^, shifting the curve leftward. Regression analysis revealed no significant difference in Ca^2+^cooperativity between control and *Syt7^M1^*, indicating the enhanced release observed is not due to alterations in the Ca^2+^cooperativity of release.

For requested experiment B, we used Fluo-4 AM to measure Ca^2+^ influx during short stimulation trains in *Syt7^M1^* mutants and controls. If SYT7 normally restricts SV release by acting as a Ca^2+^ buffer or reducing presynaptic Ca^2+^ influx, we expect to observe enhanced Ca^2+^ influx in *Syt7* mutants. In contrast, we observed significantly lower Ca^2+^ influx in *Syt7^M1^* compared to controls. We have included this data as new panels L and K in Figure 4. These data indicate SYT7 does not function as a Ca^2+^ buffer or a negative regulator of Ca^2+^ channel function to reduce release. Although it is unknown why Ca^2+^ influx is reduced in *Syt7* mutants, these data fit with our observation that BRP T-bar volume is reduced in *Syt7^M1^* as shown in Figure 4J. We suspect these changes may represent a homeostatic compensation to the enhanced release in Syt7 mutants as a mechanism to downregulate presynaptic output, indicating we may be underestimating the magnitude of enhanced release that occurs when SYT7 is absent.

> 2\) The authors put forward an interesting new model for Syt7 function that is based on anatomical localization of the Syt7 protein at the NMJ. In order to validate this model, it is essential that the tagged protein be shown to function correctly. Therefore, the authors should demonstrate that the tagged constructs achieve full rescue of the null mutation.

The reviewers note the exciting new data on subcellular localization of SYT7 at peri-AZs that we presented. However, this tagged construct is not a UAS rescue line, which could result in mis-localization of SYT7 due to overexpression. Instead, it is a much better tool -- a C-terminal CRISPR tag of endogenous SYT7, and therefore cannot be used for rescue. However, the reviewers' request to show the tag does not inactivate SYT7 function is still important to verify. Indeed, we made extensive use of SYT1 C-terminal tags in our prior research of this isoform and have not observed any disruption of SYT1 function by C-terminal tagging. Similar work using FLASH-FALI tagging of *Drosophila* SYT1 has also been done and again this tagging did not disrupt SYT1 function in rescue experiments. As such, we expected C-terminal tagging of SYT7 would be tolerated by this isoform as well. To confirm the endogenous CRISPR RFP-tagged line we used for localization studies did not inactivate SYT7, we performed TEVC recordings on the control CRISPR injection strain and SYT7^RFP^. We observed no significant differences in the evoked response between the genotypes. These data have now been added to the Results section of the manuscript.

> 3\) Related to point number 2, the authors should shore up the genetic argument that Syt7 is dose dependent. The authors should include genetic rescue to confirm the nature of the mutations. Furthermore, the authors should place their putative null mutation in trans to a deletion of the gene locus to demonstrate, unequivocally, that the null is a clear loss of function mutation. This is particularly important given that release is enhanced in the loss of function mutant background.

The extreme dosage sensitivity of SYT7 in both directions makes rescue difficult, as generating a precise match of the endogenous levels of SYT7 with GAL4 drivers is something we haven't achieved. However, we provide extensive experimental data in the manuscript to support our hypothesis of dosage-sensitivity, including data from two independently generated Syt7 null mutants (CRISPR generated null and Minos insertion before C2A leading to a premature stop). Both of these mutants lack SYT7 protein by Western as shown in Figure 1E. Heterozygotes have an intermediate phenotype for multiple phenotypes we tested, including the enhanced evoked release (shown in Figure 2) and enhanced recovery of the RRP after 10 Hz stimulation (Figure 10). In addition, overexpression of UAS-*Syt7* with *elav^C155^*-GAL4 strongly suppresses release (Figure 3) and strongly suppresses SV recovery after 10 Hz stimulation (Figure 10---figure supplement 1). These data arise from multiple independently generated genetic manipulations and provide convincing support for our conclusion that SYT7 regulates neurotransmission in a dose-dependent manner.

> 4\) Control EJC amplitudes in Figure 3 (showing the reduction in the OE condition) are equivalent to the experimental amplitudes in Figure 2 (reporting an increase in the mutant). In other words, the authors must explain why the controls are not consistent, and why the effects in one experiment are no different than the controls in another. If these are differences in genetic background, then this should be clearly stated and supported by the inclusion of additional data, possibly in a supplemental figure. Alternatively, there may be a need for additional experiments to clarify this discrepancy.

As the reviewers point out, differences in EJC amplitude can be seen in distinct genetic backgrounds. This is indeed what the reviewers are noticing in the EJC amplitudes in Figures 2 and 3, and why we always precisely match genetic backgrounds for all experiments in the lab. The larger responses in Figure 3 are due to the *elav^C155^*-GAL4 genetic background compared to the white CRISRP injection background in Figure 2. *elav^C155^*-GAL4 has larger evoked responses compared to white, and we have only made comparisons between precisely matched genetic backgrounds in each experiment described in the manuscript. The *elav^C155^*-GAL4 background is used as the appropriate control for *elav^C155^*-GAL4, UAS-*Syt7* overexpression. The control for our null mutant recordings is the precisely matched CRISPR injection line that was sequence verified.

> 5\) The authors need to come to directly address their own previously published data. In the (Sarawati et al., 2007) paper they demonstrate complete elimination of Syt7 protein at the NMJ using RNAi. However, the EPSP amplitudes at 0.1 and 0.4mM external calcium are identical to controls. This is not the phenotype that they currently present. The field will not be able to make a judgment regarding the correct answer. The Littleton lab must have thought about this issue and is the only laboratory that is able to make sense of the discrepancy. The current paper should not be published without adequate resolution of this issue, either with clear new text added to the manuscript or with experimentation.

As noted by the reviewers, a previous RNAi approach to study SYT7 did not reveal an increase in evoked release. We did address this point in the Discussion in the prior version, but have expanded that section in the current resubmission. The original Syt7 RNAi was made by my group as a double stranded exon-intron hairpin at a time before RNAi libraries were available to the field. We have now compared the results of RNAi knockdown of the two commercial RNAi lines used in our current manuscript (labeled \#1 and \#2) with the previous line (labeled \#3) from our prior publication. We drove expression of the 3 RNAi lines individually in the background of the endogenously-tagged SYT7^GFP^ CRISPR line and performed Western analysis. Indeed, the prior line (\#3) we generated did not reduce endogenous SYT7 expression, allowing us to conclude that the prior RNAi was ineffective in reducing endogenous SYT7. We've expanded the Discussion of this result in the current version and have included a Western of the result in [Author response image 1](#sa2fig1){ref-type="fig"}.

![Three RNAis were tested for pan-neuronal knockdown of SYT7^GFP^.\
Western blot was probed with anti-GFP. Lane \#1: UAS-*Syt7* RNAi\#1 (Vienna \#24989); SYT7^GFP^, lane \#2: *elav^C155^*-GAL4, UAS-Dicer2; UAS-*Syt7* RNAi\#1; SYT7^GFP^, lane \#3: UAS-*Syt7* RNAi\#2 (BDSC \#27279); SYT7^GFP^, lane \#4: *elav^C155^*-GAL4, UAS-Dicer2; UAS-*Syt7* RNAi\#2, lane \#5: *elav^C155^*-GAL4, UAS-Dicer2; SYT7^GFP^ and lane \#6: *elav^C155^*-GAL4, UAS-Dicer2; UAS-*Syt7* RNAi\#3 (Saraswati et al., 2007); SYT7^GFP^.](elife-55443-resp-fig1){#sa2fig1}

> 6\) Figure 2A, 3A, and 7B: The noise of the average mEJC traces is (almost perfectly) correlated between genotypes. How were these average traces computed? How can (regular) noise be correlated between different recordings/experimental groups? Was a noise cancelling device utilized? If so, the authors need to address how this affects amplitude and kinetic measurements and state in methods. Alternative explanations?

Indeed, we attribute these effects to gaussian noise filtering of the mini traces by the amplifier. Mini amplitudes are close to background noise levels and filtering exaggerates noise corrections during the falling phase of the response as it bleeds into background from the rig. While the decay componentof the mini data is noisy, the main conclusions of the study are not affected given we are reporting mini frequency and amplitude. As mini amplitude is calculated from base to peak, noise in the decay phase does not affect amplitude measurements. Evoked responses are much larger, and no filtering is applied for these recordings.

> 7\) The title implies that Syt7 regulates synaptic fusion. However, the study does not provide direct evidence that Syt7 negatively regulates the fusion process. I therefore suggest changing the title accordingly.

As suggested by the reviewer, we have changed the title to replace "fusion" with "release".

The title now reads "*Drosophila* Synaptotagmin 7 negatively regulates synaptic vesicle release and replenishment in a dosage-dependent manner".

[^1]: These authors contributed equally to this work.
